<SEC-DOCUMENT>0001171843-22-006969.txt : 20221101
<SEC-HEADER>0001171843-22-006969.hdr.sgml : 20221101
<ACCEPTANCE-DATETIME>20221101171732
ACCESSION NUMBER:		0001171843-22-006969
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20221101
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221101
DATE AS OF CHANGE:		20221101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anika Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		221351485

	BUSINESS ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730
		BUSINESS PHONE:		(781) 457-9000

	MAIL ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA THERAPEUTICS INC
		DATE OF NAME CHANGE:	19970114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_110122.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ANIK="http://anika.com/20221101">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_ANIK_anika.com_20221101 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20221101_20221101 -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000898437 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:EntityCentralIndexKey">0000898437</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="anik-20221101.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-11-01to2022-11-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000898437</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-01</xbrli:startDate>
        <xbrli:endDate>2022-11-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>UNITED STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>SECURITIES AND
EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>Washington, D.C.
20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 16pt"><b>FORM <span id="xdx_906_edei--DocumentType_c20221101__20221101_zMNsmxbmo2fc"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>CURRENT REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>Pursuant to Section
13 OR 15(d) of the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<b><span id="xdx_90D_edei--DocumentPeriodEndDate_c20221101__20221101_zwLFEwBcfBzj"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 1, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b><span id="xdx_908_edei--EntityRegistrantName_c20221101__20221101_zkyAVLG7Zswj"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:EntityRegistrantName">Anika Therapeutics,
Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20221101__20221101_zu2IncniMZPf"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="width: 34%; text-align: center"><b><span id="xdx_900_edei--EntityFileNumber_c20221101__20221101_zf45YPq7vay8"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:EntityFileNumber">001-14027</ix:nonNumeric></span></b></td>
    <td style="width: 33%; text-align: center"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20221101__20221101_zmZuQcuK7uWf"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:EntityTaxIdentificationNumber">04-3145961</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State or other jurisdiction of incorporation)</td>
    <td style="text-align: center">(Commission File Number)</td>
    <td style="text-align: center">(I.R.S. Employer Identification No.)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20221101__20221101_zsWxyRb1XB31"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:EntityAddressAddressLine1">32 Wiggins Avenue</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20221101__20221101_zvCoAeT8fJRi"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:EntityAddressCityOrTown">Bedford</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20221101__20221101_zIvXxcV0TjOc"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20221101__20221101_zRYhRYjSYkr5"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:EntityAddressPostalZipCode">01730</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant's telephone number, including area code:
<b><span id="xdx_908_edei--CityAreaCode_c20221101__20221101_zvdlUBjDLtr7"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:CityAreaCode">(781)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20221101__20221101_zUQnHE5jDK9g"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:LocalPhoneNumber">457-9000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--WrittenCommunications_c20221101__20221101_za6Y9nnm0Emf"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; width: 95%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
  <tr>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--SolicitingMaterial_c20221101__20221101_zQWYkGGrbzLj"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  <tr>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20221101__20221101_zLl8qQQrB2Uj"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  <tr>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_edei--PreCommencementIssuerTenderOffer_c20221101__20221101_zsqB4LmRKkXh"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 39%; text-align: center">Title of each class</td>
    <td style="border-bottom: black 1pt solid; width: 23%; text-align: center">Trading Symbol(s)</td>
    <td style="border-bottom: black 1pt solid; width: 38%; text-align: center">Name of each exchange on which registered</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b><span id="xdx_903_edei--Security12bTitle_c20221101__20221101_zBhsnn5SjX7e"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:Security12bTitle">Common Stock, par value $0.01 per share</ix:nonNumeric></span></b></td>
    <td style="text-align: center"><b><span id="xdx_900_edei--TradingSymbol_c20221101__20221101_zcBWNbbVSxm4"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" name="dei:TradingSymbol">ANIK</ix:nonNumeric></span></b></td>
    <td style="text-align: center"><b><span id="xdx_900_edei--SecurityExchangeName_c20221101__20221101_zns0tkoY6Xt8"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ Global Select Market</ix:nonNumeric></span></b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20221101__20221101_zXKNqHQ2mmv2"><ix:nonNumeric contextRef="From2022-11-01to2022-11-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. &#9;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 1, 2022, Anika Therapeutics, Inc. (the &#8220;Company&#8221;)
issued a press release announcing that Cingal<b><i><sup>&#174;</sup></i></b> met its primary endpoint in a Phase III study (Cingal 19-01),
demonstrating superiority over triamcinolone hexacetonide (TH) steroid alone at 26 weeks post-treatment. A copy of the press release is
attached hereto as Exhibit 99.1 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>A top-line summary of the Company&#8217;s three Phase III clinical
studies of Cingal is provided below. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Cingal 13-01 (Cingal vs placebo vs Monovisc<b><sup></sup></b>
alone)</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Cingal 13-01 Phase III study was a multicenter, randomized, double-blind,
placebo-controlled active comparator study that evaluated subjects with osteoarthritis (OA) (Kellgren-Lawrence Grades K-L I/II/III) at
23 sites in Eastern Europe and Canada. In total, 368 patients were randomized into three treatment arms (Cingal (149 subjects), Monovisc&#174;
alone (150 subjects) and placebo (saline) (69 subjects)).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cingal met the primary endpoint of this study and demonstrated superiority
over placebo based on change from baseline in the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Pain Index at 12 weeks
post-treatment (p=0.0013). Cingal also demonstrated superiority over saline at 26 weeks (p=0.0027). Cingal demonstrated superiority over
Monovisc based on change from baseline in WOMAC Pain Index at week one (p=0.0367) and week three (p=0.0289). WOMAC Pain Index is a widely
used set of standardized questionnaires for health professionals to evaluate the condition of patients with osteoarthritis of the knee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As expected, there were no statistically significant differences between
the Cingal and Monovisc treatment arms for change in WOMAC Pain Index at weeks 6, 12, 18 or 26, demonstrating that the HA component of
Cingal provides the durable pain relief. The percent of Cingal subjects who met criteria for the OMERACT-OARSI Responder Index at 26 weeks
was 92%. OMERACT-OARSI is a recognized method of evaluating responder rates based on meeting thresholds for improvement in pain and function.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cingal was well-tolerated in this study, with only transient and non-serious
adverse events (e.g., arthralgia, injection site bruising) related to the study injection.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Cingal 16-02 (Cingal vs Monovisc alone vs TH steroid alone)</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Cingal 16-02 Phase III study was a multicenter, randomized, double-blind,
active comparator study that evaluated subjects with OA (Kellgren-Lawrence Grades K-L I/II/III) at 18 sites in Eastern Europe. In total,
557 patients were randomized into three treatment arms (Cingal (252 subjects), Monovisc alone (251 subjects) and TH steroid alone (74
subjects)).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In this study, while Cingal was numerically better than TH steroid
alone after 26 weeks in change from baseline as measured by WOMAC Pain, the primary endpoint of superiority was not established. Likewise,
while Cingal was numerically better than Monovisc alone at week 3 post-treatment, superiority was not established. The percent of Cingal
subjects who met criteria for the OMERACT-OARSI Responder Index at 26 weeks was 91%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cingal was well-tolerated in this study, with only transient and non-serious
adverse events (e.g., arthralgia, injection site pain, swelling, injection site reaction) related to the study injection.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Of note, the Cingal 16-02 study was an all-active study (it did not
include a placebo arm), leading to the concern of expectation bias on the part of subjects, meaning that all patients received active
treatment and therefore expected a pain improvement benefit. The design of the Cingal 19-01 study included a small placebo arm to address
this potential bias, as well as modifying eligibility criteria to enroll patients with more severe OA (e.g., exclude K-L grade I patients
and make baseline WOMAC Pain 50 mm instead of 40 mm).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Cingal 19-01 (Cingal vs TH steroid alone)</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Cingal 19-01 Phase III study was a multicenter, randomized, double-blind,
placebo-controlled, active comparator study that evaluated subjects with more severe OA (Kellgren-Lawrence Grades (K-L) II/III) at 26
sites in the United States. In total, 231 subjects were randomized into three treatment arms (Cingal (99 subjects), TH steroid alone (99
subjects) and placebo (saline) (33 subjects)).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The pre-specified primary analysis of the primary endpoint of the study
was to evaluate change from baseline in knee pain as measured by the WOMAC Pain Index at 26 weeks post-treatment, comparing the Cingal
arm to the TH steroid arm.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The 19-01 study met its primary endpoint and demonstrated superiority
of Cingal over TH steroid at 26 weeks post-treatment based on change in WOMAC Pain Index from baseline (p=0.0406). The figure below shows
the change in WOMAC Pain Index from baseline across all measured timepoints.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><img src="graph.jpg" alt="" style="height: 215px; width: 400px" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, Cingal demonstrated strong performance for pain improvement
with 66% improvement in WOMAC Pain Index (-44.3mm from baseline) and 90% of subjects met the criteria as OMERACT-OARSI Responders at 26
weeks post-treatment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cingal was well-tolerated in the study, with only transient and non-serious
adverse events (e.g., arthralgia, injection site pain, swelling, stiffness, injection site reaction, injection site bruising, and transitory
decreased range of motion) related to the study injection.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Cautionary Note Regarding Forward-Looking Statements&#9;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Current Report on Form 8-K includes&#160;&#8220;forward-looking
statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation,
statements about the results of the three completed Phase III clinical studies of Cingal, the clinical benefits and safety profile of
Cingal, the timing and outcome of a planned meeting with the United States Food and Drug Administration (FDA) about the U.S. regulatory
pathway for Cingal, the U.S. regulatory pathway generally, including the need for additional Phase III pivotal studies, and, if approved,
the commercialization of this product candidate. The FDA may require that the Company conduct a single, full factorial pivotal study of
Cingal confirming the clinical results observed in the Phase III clinical trials completed to date prior to any regulatory submission
for approval. Forward-looking statements can be identified by such words as &#8220;will,&#8221; &#8220;likely,&#8221; &#8220;may,&#8221;
&#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;designed,&#8221;
&#8220;develop,&#8221; &#8220;would,&#8221; &#8220;future,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; and other expressions that are
predictions of or indicate future events and trends and that do not relate to historical matters. Any forward-looking statements are based
on management&#8217;s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual
results to differ materially from those set forth in, or implied by, such forward-looking statements. These risks and uncertainties include,
but are not limited to, (i) the Company&#8217;s ability to successfully commence and/or complete clinical trials of its products on a
timely basis or at all; (ii) the Company&#8217;s ability to obtain pre-clinical or clinical data to support domestic and international
pre-market approval applications, 510(k) applications, or new drug applications, or to timely file and receive FDA or other regulatory
approvals or clearances of its products; (iii) that such approvals will not be obtained in a timely manner or without the need for additional
clinical trials, other testing or regulatory submissions, as applicable; (iv) the Company&#8217;s research and product development efforts
and their relative success, including whether we have any meaningful sales of any new products resulting from such efforts; (v) the cost
effectiveness and efficiency of the Company&#8217;s clinical studies, manufacturing operations, and production planning; (vi) the strength
of the economies in which the Company operates or will be operating, as well as the political stability of any of those geographic areas;
(vii) future determinations by the Company to allocate resources to products and in directions not presently contemplated; (viii) the
Company&#8217;s ability to successfully commercialize its products, in the&#160;U.S.&#160;and abroad; (ix) the Company&#8217;s ability
to provide an adequate and timely supply of its products to its customers; and (x) the Company&#8217;s ability to achieve its growth targets.
For a discussion of other risks and uncertainties, and other important factors, any of which could cause the Company's actual results
to differ from those contained in the forward-looking statements, see the section entitled &#8220;Risk Factors&#8221; in the Company&#8217;s
Form 10-K for the year ended December 31, 2021 and subsequent filings with the Securities and Exchange Commission. All information in
this Current Report on Form 8-K is as of the date hereof, and the Company undertakes no duty to update this information unless required
by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(d) Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: bottom; width: 12%"><b><span style="text-decoration: underline">Exhibit Number</span></b></td>
    <td style="vertical-align: bottom; width: 88%"><b><span style="text-decoration: underline">Description</span></b></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td><a href="exh_991.htm">99.1</a></td>
    <td><a href="exh_991.htm">Press Release of Anika Therapeutics, Inc. dated November 1, 2022</a></td></tr>
  <tr>
    <td>104</td>
    <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>Anika Therapeutics, Inc.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 48%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>Date: November 1, 2022</td>
    <td>By: </td>
    <td><span style="text-decoration: underline">&#160;&#160;/s/ Cheryl R. Blanchard </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Cheryl R. Blanchard</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>President and Chief Executive Officer</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="margin: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZizZBXXRpURGrSBFxG+1Ugm2mTNKqR/KWxhZxGBiG/9//QozEmlamQobzIs/giHVTaY+QY4mM9orBkW62CYSb4804z9r6/v2BKQUGAzMby/klCL21Mw6LBKScxHKiFEiVTBUcdiL66inZ0hRovdEVaFvAgalhg17za0g46idZql991QnZGbIhbhwP8htULBXsqdMP4ruDLEtFNOonEmumtvnWtM5TDcsK69DlBvS/0QcVGElE -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh_991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><html lang="en-US"><head><title>EdgarFiling</title><meta content="text/html; charset=windows-1252" /><meta name="GENERATOR" content="MSHTML 8.00.7601.18094" /></head><body bgcolor="#ffffff"><p style="text-align: right;"><font style="font-size: 10pt"><b>Exhibit
                                            99.1</b></font></p><p style="text-align: center;"><font style="font-size: 10pt"><b>Anika&#8217;s
                                            Cingal&#174; Successfully Achieves Primary Endpoint in&#160;Third Phase III Study</b></font></p><p style="text-align: center;"></p><p><p align="center"><font style="font-size: 10pt"><i>Study Demonstrated Superiority of Cingal, a Single-Injection Hyaluronic Acid-Based
 Viscosupplement Combined with Fast-Acting Steroid, Over Steroid Alone, for Osteoarthritis Pain Relief at 26 Weeks</i><br /></font></p>  <p align="center"><font style="font-size: 10pt"><i>Study
                                            Builds on Prior Phase III Study Data that Demonstrated Superiority over Placebo and Hyaluronic
                                            Acid-Based Viscosupplement Alone</i></font></p>  <p align="center"><font style="font-size: 10pt"><i>Company
                                            Plans to Meet with FDA to Discuss Next Steps for U.S. Regulatory Approval</i></font></p>  <p align="center"><font style="font-size: 10pt"><i>Company
                                            Actively Assessing Options to Advance Cingal, Including Through Potential Commercial Partnerships</i></font></p>  <p align="left"><font style="font-size: 10pt">BEDFORD,
                                            Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global
                                            joint preservation company focused on early intervention orthopedics, today announced that
                                            Cingal<sup>&#174;</sup> met its primary endpoint in a Phase III Study (Cingal 19-01), demonstrating
                                            superiority over triamcinolone hexacetonide (TH) steroid alone at 26 weeks post-treatment.
                                            The Cingal 19-01 Phase III study is the third completed Phase III study of Cingal and, together
                                            with previous studies, has now demonstrated superiority over each of its active ingredients
                                            and placebo. Across the three completed Phase III studies, Cingal demonstrated a mean 71%
                                            pain improvement from baseline and a mean 91% of Cingal subjects were deemed to be Responders.</font></p>  <p align="left"><font style="font-size: 10pt">Cingal
                                            is a combination product of cross-linked hyaluronic acid (HA) proven to provide long lasting
                                            pain relief through 6 months plus TH steroid to provide fast, short-term pain relief, both
                                            of which has been approved for sale in the United States, to treat the pain of knee osteoarthritis
                                            (OA). Cingal is currently sold in more than 35 countries outside the United States.</font></p>  <p align="left"><font style="font-size: 10pt">Anika
                                            will engage with the U.S. Food and Drug Administration (FDA) in the coming months on next
                                            steps for U.S. regulatory approval. In parallel, Anika is exploring the potential to advance
                                            Cingal through commercial partnerships in the U.S. and select Asian markets. These efforts
                                            will inform next steps, including if and how to proceed with another clinical trial in the
                                            United States.</font></p>  <p align="left"><font style="font-size: 10pt">&#8220;We
                                            are excited that Cingal successfully met the primary endpoint of this third Phase III study,
                                            and again confirmed the strong and durable pain relief observed in previous studies,&#8221;
                                            said Anika&#8217;s President and CEO, Cheryl R.&#160;Blanchard, Ph.D. &#8220;The successful
                                            results of this study represent a significant clinical milestone for Anika, and we look forward
                                            to meeting with the FDA to discuss next steps for U.S. regulatory approval. We believe that
                                            Cingal offers compelling clinical benefits to patients in terms of pain relief, durability
                                            of pain relief, responder rates and safety profile based on our established, real-world success
                                            with Cingal in over 35 countries outside the United States, as well as the totality of the
                                            data observed in our three completed Phase III studies. Cingal is a game-changing, next generation
                                            product for patients suffering from osteoarthritis, and we believe these clinical data position
                                            us well to further advance Cingal.&#8221;</font></p>  <p align="left"><font style="font-size: 10pt"><b>Significant
                                            Market Opportunity Underscored by Successful Commercialization of Cingal in Over 35 Countries
                                            Outside the United States</b></font></p>  <p align="left"><font style="font-size: 10pt">Since
                                            2016, Anika has successfully commercialized Cingal in over 35 countries outside the United
                                            States and controls full global rights. Anika is focused on further unlocking the clinical
                                            and commercial potential of Cingal in the United States and select Asian markets. A United
                                            States approval of Cingal by the FDA would significantly bolster Anika&#8217;s knee OA pain
                                            management portfolio with a market expanding, next generation OA product. Cingal has the
                                            potential to address a true unmet medical need for the more than 32 million patients in the
                                            United States suffering from osteoarthritis, with an estimated next generation OA U.S. market
                                            opportunity of at least $1 billion with additional expansion opportunities internationally.</font></p>  <p align="left"><font style="font-size: 10pt"><b>Summary
                                            of the Cingal 19-01 Phase III Study Results</b></font></p>  <p align="left"><font style="font-size: 10pt">The
                                            Cingal 19-01 Phase III study was a multicenter, randomized, double-blind, parallel group,
                                            placebo-controlled, active comparator study that evaluated OA subjects at 26 sites in the
                                            United States. In total, 231 subjects were randomized into three treatment arms (Cingal (99
                                            subjects), TH steroid alone (99 subjects) and placebo (saline) (33 subjects)). Anika conducted
                                            the Cingal 19-01 Phase III study with the aim of de-risking the Cingal clinical development
                                            program by demonstrating that a study that was placebo-controlled and enrolled patients with
                                            a higher pain score at baseline would show superiority of Cingal over TH steroid at 26 weeks.</font></p>  <p align="left"><font style="font-size: 10pt">The
                                            pre-specified primary analysis of the primary endpoint of the study was to evaluate change
                                            from baseline in knee pain as measured by the Western Ontario and McMaster Universities Osteoarthritis
                                            (WOMAC) Pain Index at 26 weeks post-treatment, comparing the Cingal arm to the TH steroid
                                            arm. WOMAC Pain Index is a widely used set of standardized questionnaires for health professionals
                                            to evaluate the condition of patients with osteoarthritis of the knee.</font></p>  <p align="left"><font style="font-size: 10pt">The
                                            19-01 study met its primary endpoint and demonstrated superiority of Cingal over TH steroid
                                            at 26 weeks post-treatment based on change in WOMAC Pain Index from baseline (p=0.0406).
                                            The figure below shows the change in WOMAC Pain Index from baseline across all measured timepoints.</font></p>  <p align="left"><font style="font-size: 10pt">In
                                            addition, Cingal demonstrated strong performance for pain reduction with 66% improvement
                                            in WOMAC Pain Index (-44.3mm from baseline) and 90% of subjects were deemed to be OMERACT-OARSI
                                            Responders at 26 weeks post-treatment. OMERACT-OARSI is a recognized method of evaluating
                                            responder rates based on improvement in pain and function.</font></p>  <p align="left"><font style="font-size: 10pt">Cingal
                                            was well-tolerated in the study, with only transient and non-serious adverse events (<i>e.g.</i>,
                                            arthralgia, injection site pain, swelling, stiffness) related to the study injections.</font></p>

<p style="text-align: left"><font style="font-size: 10pt"><img src="cingal.jpg" alt="" style="height: 274px; width: 500px">&nbsp;<br /></font></p>  <p align="left"><font style="font-size: 10pt"><b>Summary
                                            of the Cingal Phase III Clinical Program</b></font></p>  <p align="left"><font style="font-size: 10pt">The
                                            Cingal 19-01 Phase III study is the third completed Phase III study of Cingal in OA patients.
                                            A total of 741 patients have been treated with Cingal in this clinical program yielding consistent
                                            and significant pain reduction for six months in this difficult to treat patient population.</font></p>  <p align="left"><font style="font-size: 10pt">In
                                            combination, Anika&#8217;s Phase III program has now demonstrated superiority of Cingal over
                                            each of its active ingredients and placebo. Cingal demonstrated superiority over the HA component
                                            (Monovisc<sup>&#174;</sup>) at 1 week and 3 weeks post-treatment in the 13-01 study (p=0.0367
                                            and p=0.0289), superiority over the TH steroid component at 26 weeks post-treatment in the
                                            19-01 study (p=0.0406), and superiority over placebo at 12 weeks and 26 weeks post-treatment
                                            in the 13-01 study (p=0.0013 and p=0.0027).</font></p>  <p align="left"><font style="font-size: 10pt">Percent
                                            improvement for Cingal in change of WOMAC Pain Index from baseline at 26 weeks post-treatment
                                            was 72% for the 13-01 study, 73% for the 16-02 study, and 66% for the 19-01 study in a more
                                            difficult patient population (mean 71% improvement across all three studies). In addition,
                                            the percent of Cingal subjects who met criteria for the OMERACT-OARSI Responder Index at
                                            26 weeks was 92% in the 13-01 study, 91% in the 16-02 study, and 90% in the 19-01 study (mean
                                            91% Responders across all three studies). Cingal was well-tolerated with a consistent safety
                                            profile across all three studies, with no serious adverse events (SAEs) related to the Cingal
                                            injection.</font></p>  <p align="left"><font style="font-size: 10pt"><b>About
                                            the FDA Requirements for Cingal NDA</b></font></p>  <p align="left"><font style="font-size: 10pt">The
                                            FDA previously advised Anika that it considers Cingal to be a drug-drug combination product
                                            that must meet the FDA&#8217;s fixed combination rule and thus demonstrate the contribution
                                            of each component to the therapeutic effect in a single, full factorial pivotal study. The
                                            agency has advised Anika that, because the TH steroid component is intended to provide pain
                                            reduction over the short-term while the HA component (Monovisc) is intended to be long-acting,
                                            it interprets this rule as requiring that Cingal demonstrate superior pain reduction over
                                            the two individual components at different time points (<i>i.e.</i>, Cingal must demonstrate
                                            superiority on both the comparison to HA in the short term and the comparison to TH steroid
                                            in the long term) to support the intended treatment effect. As noted above, in combination,
                                            Anika&#8217;s Phase III program has now demonstrated superiority of Cingal over each of its
                                            active ingredients and placebo. Based on these data, Anika intends to engage with the FDA
                                            in the coming months on next steps for U.S. regulatory approval.</font></p>  <p align="left"><font style="font-size: 10pt"><b>About
                                            Anika</b></font></p>  <p align="left"><font style="font-size: 10pt">Anika
                                            Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and
                                            delivers meaningful advancements in early intervention orthopedic care. Leveraging our core
                                            expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide
                                            minimally invasive products that restore active living for people around the world. Our focus
                                            is on high opportunity spaces within orthopedics, including osteoarthritis pain management,
                                            regenerative solutions, sports medicine soft tissue repair and bone preserving joint technologies,
                                            and our products are efficiently delivered in key sites of care, including ambulatory surgery
                                            centers. Anika&#8217;s global operations are headquartered outside of Boston, Massachusetts.
                                            For more information about Anika, please visit www.anika.com.</font></p>  <p align="left"><font style="font-size: 10pt">ANIKA,
                                            ANIKA THERAPEUTICS, CINGAL, MONOVISC, and the Anika logo are registered trademarks of Anika
                                            Therapeutics, Inc. or its subsidiaries.</font></p>  <p align="left"><font style="font-size: 10pt"><b>Forward-Looking
                                            Statements </b></font></p>  <p align="left"><font style="font-size: 10pt">This
                                            press release may contain forward-looking statements, within the meaning of Section 27A of
                                            the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of
                                            1934, as amended, concerning the Company's expectations, anticipations, intentions, beliefs
                                            or strategies regarding the future which are not statements of historical fact, including
                                            statements about the results of the three completed Phase III clinical studies of Cingal
                                            (including Study 19-01), the clinical benefits and safety profile of Cingal, the timing and
                                            outcome of a planned meeting with the FDA about the U.S. regulatory pathway for Cingal, the
                                            U.S. regulatory pathway generally, including the need for additional Phase III pivotal studies,
                                            and, if approved, the commercialization of this product candidate. The FDA may require that
                                            the Company conduct a single, full factorial pivotal study of Cingal confirming the clinical
                                            results observed in the Phase III clinical trials completed to date prior to any regulatory
                                            submission for approval. These statements are based upon the current beliefs and expectations
                                            of the Company's management and are subject to significant risks, uncertainties, and other
                                            factors. The Company's actual results could differ materially from any anticipated future
                                            results, performance, or achievements described in the forward-looking statements as a result
                                            of a number of factors including, but not limited to, (i) the Company's ability to successfully
                                            commence and/or complete clinical trials of its products on a timely basis or at all; (ii)
                                            the Company's ability to obtain pre-clinical or clinical data to support domestic and international
                                            pre-market approval applications, 510(k) applications, or new drug applications, or to timely
                                            file and receive FDA or other regulatory approvals or clearances of its products; (iii) that
                                            such approvals will not be obtained in a timely manner or without the need for additional
                                            clinical trials, other testing or regulatory submissions, as applicable; (iv) the Company's
                                            research and product development efforts and their relative success, including whether we
                                            have any meaningful sales of any new products resulting from such efforts; (v) the cost effectiveness
                                            and efficiency of the Company's clinical studies, manufacturing operations, and production
                                            planning; (vi) the strength of the economies in which the Company operates or will be operating,
                                            as well as the political stability of any of those geographic areas; (vii) future determinations
                                            by the Company to allocate resources to products and in directions not presently contemplated;
                                            (viii) the Company's ability to successfully commercialize its products, in the U.S. and
                                            abroad; (ix) the Company's ability to provide an adequate and timely supply of its products
                                            to its customers; and (x) the Company's ability to achieve its growth targets. Additional
                                            factors and risks are described in the Company's periodic reports filed with the Securities
                                            and Exchange Commission, and they are available on the SEC's website at www.sec.gov. Forward-looking
                                            statements are made based on information available to the Company on the date of this press
                                            release, and the Company assumes no obligation to update the information contained in this
                                            press release.</font></p>  <p align="left"><font style="font-size: 10pt"><b>For
                                            Investor Inquiries:</b></font></p>  <p align="left"><font style="font-size: 10pt">Mark
                                            Namaroff<br />Anika Therapeutics, Inc.<br />Vice President, Investor Relations, ESG and Corporate
                                            Communications<br />Direct: 781-457-9287<br />mnamaroff@anika.com</font></p>  <p align="left"></p> </p><p /><font style="font-size: 10pt"></body></html></font>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>anik-20221101.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qlZs7xRiXgen8uAbXMsOaOKGaOdx5B76ekxt218HclKnyUnyKF2hCV3I5em4YAD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:ANIK="http://anika.com/20221101" elementFormDefault="qualified" targetNamespace="http://anika.com/20221101">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://anika.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="anik-20221101_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="anik-20221101_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>anik-20221101_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>anik-20221101_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://anika.com/role/Cover" xlink:href="anik-20221101.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://anika.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>cingal.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cingal.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %. F$# 2(  A$! Q$!_\0
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MC47_ $%=8_\  Y_\: -NBL3_ (1J+_H*ZQ_X'/\ XT?\(U%_T%=8_P# Y_\
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MK$_X1J+_ *"NL?\ @<_^-'_"-1?]!76/_ Y_\: -NBL3_A&HO^@KK'_@<_\
MC1_PC47_ $%=8_\  Y_\: -NBL3_ (1J+_H*ZQ_X'/\ XT?\(U%_T%=8_P#
MY_\ &@#;HK$_X1J+_H*ZQ_X'/_C1_P (U%_T%=8_\#G_ ,: -NBL3_A&HO\
MH*ZQ_P"!S_XT?\(U%_T%=8_\#G_QH VZ*Q/^$:B_Z"NL?^!S_P"-'_"-1?\
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MO_DN'C+_ *\[3_T&J'QVTJQD\%G4WMD:]2X@B25LDJI?D =!G- 'J%Q=6]I
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MJSO?%>J:#=2$_P!JKX474(V'7ST8/G\<'\Z /H*[OK/3XA+>W4%M&3M#S2!
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M2V\<\3SQ8,D:N"R9Z9'49KQ/Q%XCU/Q)\.;*;5K-X+FV\16\'F- \(N%!R)
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M#ROR_2MO0/!.J:[X.%IXJN+^WN8+]KK2Y3<!KNS08V;G&06'->F9'J*,CU%
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M@_\ 0-C_ .^F_P :VJ* ,7_A$=!_Z!L?_?3?XT?\(CH/_0-C_P"^F_QK:HH
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M - V/_OIO\:VJ* ,7_A$=!_Z!L?_ 'TW^-'_  B.@_\ 0-C_ .^F_P :VJ*
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M0!7^TR?\^LOZ?XT?:9/^?67]/\:L44 5_M,G_/K+^G^-'VF3_GUE_3_&K%%
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M 6**K_8H_P"]+_W\-'V*/^]+_P!_#0!8HJO]BC_O2_\ ?PT?8H_[TO\ W\-
M%BBJ_P!BC_O2_P#?PT?8H_[TO_?PT 6**K_8H_[TO_?PT?8H_P"]+_W\- %B
MBJ_V*/\ O2_]_#1]BC_O2_\ ?PT 6**K_8H_[TO_ '\-'V*/^]+_ -_#0!8H
MJO\ 8H_[TO\ W\-'V*/^]+_W\- %BBJ_V*/^]+_W\-'V*/\ O2_]_#0!8HJO
M]BC_ +TO_?PT?8H_[TO_ '\- %BBJ_V*/^]+_P!_#1]BC_O2_P#?PT 6**K_
M &*/^]+_ -_#1]BC_O2_]_#0!8HJO]BC_O2_]_#1]BC_ +TO_?PT 6**K_8H
M_P"]+_W\-'V*/^]+_P!_#0!8HJO]BC_O2_\ ?PT?8H_[TO\ W\- %BBJ_P!B
MC_O2_P#?PT?8H_[TO_?PT 6**K_8H_[TO_?PT?8H_P"]+_W\- %BBJ_V*/\
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M:[6&2&YCWM@!788=3GG/0]^W2^#8+"+1I9+'6HM9>>X>6ZOHW1A),<;N$X7
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MP8_X2VV\#02:):64UM/K'[XW+XQ!M4.5P>N1_P#6H ]\HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *Q/%O\ R+5S_OQ?^C%K;K$\6_\ (M7/^_%_Z,6@#;HHHH *
MQ=5_Y&+0/^NLW_HIJVJQ=5_Y&+0/^NLW_HIJ -JBBB@#$\6_\BY-_P!=8/\
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MN)RX=P<E6D4[N>N/PH ]-LKVVU&RAO+.99K>90\<B'AA4>J?\@F]_P"N#_\
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M6+_O@_XT 6**K[;O_GK%_P!\'_&C;=_\]8O^^#_C0!8HJOMN_P#GK%_WP?\
M&C;=_P#/6+_O@_XT 6**K[;O_GK%_P!\'_&C;=_\]8O^^#_C0!8HJOMN_P#G
MK%_WP?\ &C;=_P#/6+_O@_XT 6**K[;O_GK%_P!\'_&C;=_\]8O^^#_C0!8H
MJOMN_P#GK%_WP?\ &C;=_P#/6+_O@_XT 6**K[;O_GK%_P!\'_&C;=_\]8O^
M^#_C0!8HJOMN_P#GK%_WP?\ &C;=_P#/6+_O@_XT 6**K[;O_GK%_P!\'_&C
M;=_\]8O^^#_C0!8K$\6_\BU<_P"_%_Z,6M/;=_\ /6+_ +X/^-8WBI;D>';C
MS)(RN^+("D'_ %B^] '0T444 %8NJ_\ (Q:!_P!=9O\ T4U;58NJ_P#(Q:!_
MUUF_]%-0!M4444 8GBW_ )%R;_KK!_Z-2MNL3Q;_ ,BY-_UU@_\ 1J5MT >+
MR^&= N+RY/AWX?ZGJ5BL[I)=1:PUK&\@.'**T@W 'C=C&01VKT7P1#HT/AT+
MHEM=6MOYS^;;W3NTL4H.&5M[$@C'3..XZUB6%WXF\-VITW2_#L6O:='+(;:[
MMM0BB(0N3M</_$"2,C(./6NA\*:9?:=I]S+JGDB_OKJ2[FC@)*1EL (">N%4
M<]SF@"/Q-?Z1/:W'A^^U:#3[F_MV2)I<#J",KN^4D8)Q7/6<-UH\D-U?_%%;
MBQM<-+%-%;*'0=BP&[\<YKNKRQM-0MVM[VVAN86!!CF0.ISQT-9%IX'\*6-R
MES:^'-*AG3.V1+1 1D8X.* ->POK;4[*.\LY?-MY02C@$!AG&1GMQ5BC&!@4
M4 %%8_B*\DL;))EU.#3H]^'FE@,O;@ 9%<BOC#59+#09KR_M-,BNX+AYKO[*
M9$8HRA"!N^3<I+8)R.G:@#T:JFJ?\@F]_P"N#_\ H)J2RD\VQ@D%S'<[D!\^
M, +)Q]X8)X-1ZI_R";S_ *X/_P"@F@"+0?\ D7M-_P"O6+_T$5YG^T/;-)X!
MM+I.&MM0C;=Z95A_/%>C:'=VZ^'].5ID!%K&",_[(KC_ (TK#?\ PLU54E1F
MB,<H /HXH WO /C"W\;^%X]5M[=[?:YA>)V#$,N.X['(KJ*\/_9QU&-?#.L6
MDL@7R[M9 &/9D _]EKVG[9;?\]X_^^J )ZP]2\+:5J'B*P\0W-O))J.G(RVY
M60@<Y[=#U/YUJ_;+;_GO'_WU1]LMO^>\?_?5 &7X5UR\\0:/]MOM&NM)F\UX
M_L]S][ /#=!P?Z5MUS7B+1X=?NM)F77+FQ&GW0N"EM)@3X_A;VX_4TMGJ.N-
MXOOX[M+!?#ZP*;29),RM)QD,,].O;L* .DHKCM/\;7'_  CNKZMK.B7-A]@E
MD$=N#ODGC7HRCCK^7%6)/B%H%IX<TW6]1N)+&WORJQ1SQG>&;L0,XZ'GI0!U
M-%9\NO:3#J$%A+J-LEY.I:*!I '<#J0.]6!?6A8J+F(LO4!QD?6@"Q14/VRW
M'69/SI/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^
M^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/M
MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_S
MWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[
MZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH G
MHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[
M9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\
M]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^
M^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/M
MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GHJ#[9;?\]X_^^J/MEM_S
MWC_[ZH GHJ#[9;?\]X_^^J/MEM_SWC_[ZH GK$\6_P#(M7/^_%_Z,6M3[9;?
M\]X_^^JQO%5S!)X=N%25&8O%@ _]-%H Z"BBB@ K%U7_ )&+0/\ KK-_Z*:M
MJL75?^1BT#_KK-_Z*:@#:HHHH Q/%O\ R+DW_76#_P!&I6W6)XM_Y%R;_KK!
M_P"C4K;H \7N[_P[>Z[<6?A;1[C2]44LCW1U#^RTX;.X)DF12W!.S->G>%K/
M7;+1A%XAU"*^OC(S[XDVA%.,)G W8Y^; SZ5@ZGX>\4^)Q+;ZK-H=E8L60+%
M:?:Y63^$[I %4^VTUT'AOP[:^&-,:QM)IY5>5IG:9@26.,X  "CCH!@4 ;%%
M%% !398TFB>*10T;J593T(/44ZB@#&DTNYTVVBA\.)I]I&'9I(986*MD=1M(
MP>/QK.T_0-:T33_(TR]L'>>66XN?M%NVP2R-N)C"L,*,XP?SKIYIH[>%YIG6
M.*-2SNQP% Y))K+D\4:'%IEMJ+:G;_8[G/D2ALB3'7&.N,4 2^']&B\/Z#::
M5#*TJ6Z;=[  L222<#H,D\=JGU3_ )!-[_UP?_T$U/!/#=6\<]O*DL,BAD=#
MD,#T(-0:I_R";W_K@_\ Z": (-"53X>TWY1_QZQ=O]D5E_$&Q%]\/=?MU49:
MRD8<>@S_ $K6T'_D7M-_Z]8O_014NJ6WVW2+VUQGSH'CQ]5(_K0!PGP0:WF^
M%NFO'!$CAI$D94 +L'/)]3C%3>.M:\=Z)JD$OAOP[:ZII?E9E'67?DY& 0<8
MQT!K$_9ZN?,\!7=H3S:W\B_F%->MT >3Z#\9DN]9M-'UWPMJ.F7MS(L*GRRR
M[R<=" 0/SKU?8O\ ='Y4A1&9695)7H2.E.H :%0YP%..M+L7^Z/RKR35_@M>
M?VM<ZKX<\7ZEIMS/*TI5W9@"3DC*D''US70^ ]%\>Z/?74?BK7;34[#R\6^P
M$RA\CDG:.,9ZDT =UL7^Z/RJ&XLK6[14N;:&958.HD0, PZ$9[U6US55T/1+
MS4WMY[E;:(R&&!=SOCL!7G6G?M >#KI@EZM_I\F<,)H-P!^JDG]* /0KCP]I
M%WK=KK,]A#)J-JAC@N"/F13G(';N?S-4]/\ "&F:9K^K:U:F<7FJ!1.6DRJX
M'&T=JO:+KNF>(M.74-)O([NU8E1)&>A'4$=0:T: ./M?">LZ/X)N](TSQ'/-
MJDC,\&H7J!S&20<8YXQG\3FI]33Q=::?H<6F#3[VZ66--4FG&P,F/G9 .ASD
M_P!*ZFB@#!EN]>7QG!91Z3;MH+6Q>2^,@WK+D_+M_+MWZ\5%I>JZU<ZGKL-_
MH'V>ULWQ8RK(";L8/Y=!^=='10!QT7BO54\!R^(+OPG>1W\9(_LM>9&&[&>F
M<8YZ=JM:IXK.E0Z"\FA7\KZK*D31Q1AC:E@#\_TS^AKIZ* ,%_$UHGC./PR;
M&[-P]L;D7 A_<@9Q@MZ\4S3/%VE:K>:W;0QW"-HS[+IY8=JG@DE3WZ&NAIH1
M06(4#=][CK]: .8@\?>&YO!A\6?:6CTE6*F1X6# [MN-N,]:OW?B?0K%-+:Z
MOH8EU5E2R+*?WI8 C'''4=?45I26%G+9FSDM8'M6&#"T8*'O]WI3+G2["\:V
M:YLK>9K5P]N9(PWE,.A7/0_2@"$ZSI(UL:*;RW_M,Q><+;(W[/7%.M-5TN^D
MNX[2\MIGLWV7(1P?*;T;TI3H^FG61K!L8/[1$7D_:M@W[,YVY]*H0Z-X;TLZ
MFT4%G;_VD2]Z=X'G9!!)R?<]/4T :,>H:=+8"_CN[5K,\_:!(OE]<?>Z=>*L
M%X%V;FC&\X3)'S'V]:YQ_ GAJX\&_P#",1V>W1F(<1QRMUW;L[LY//-5/%.G
M^$+:709]>U&.P_LJ026(>Z\L$J!P0?O 8'^30!V&U,XPN?I2[%_NC\J\W'B7
MX>#QP/$8\6PF^>V%J(A<YAQGKC'7\:Z72?",.F#73'JE_-_;$K2LTDV3!N!'
M[L]NO7V'I0!T>Q?[H_*DVH/X5Y]J\KU8>"M)\)-X!U?QG/#+!AI)GG/G#+;P
M"<$8YZ>F*UOM/@GQ?K.@):>)A/>Z4_F6T,%Y@RX ^^/XONCWZT =[^[W[/DW
M8SM[XIJR0,'*O&1&</@CY3[^E9*>%=/3QA)XH#7/]H26WV8J93Y>W(_A]>*R
M],T/PEI(URWM[Z$C5I7DO8Y+P,<L""!SE>IH Z5[RQ2S%X]S;+:G_EL9%">G
MWNE+-=V5O+!%-<01R7!VPH[@&0^BCO\ A7.Q^!?#%SX,C\++#Y^D1,&""<EM
MV[=G<#GJ:TK[PKHFI7>EW5W8))-I1W6;%B/*Z>_/0=<]* +POK!M1;3A<VYO
M5C\UK<.-X3INV]<5!!K6CW45[+!?VDD=BS)=,D@(A*C)#>F*:GAW28_$4GB!
M;)!JLD(@:YR<E/3&<=ASC/%-LO#.B:=%J$5IIL$4>HNTEVH&1,6SG.?J>/>@
M".;Q3X>@T%-=DU2T72W("W6[*$DXP#]:DO?$.BZ??:=9W=[!%<:BVVT0_P#+
M4\=/S'YTA\+:$V@IH;:3:MI:8*VK1@H"#G./7/-6Y](TZZN+2>XL;>6:S.;9
MWC!,)QCY3V_"@"K'XAT:;Q)-X>CNHVU6&$3O;[3D(<<YQCN./>JMEXQ\/:C8
MZM>6MXLD&DNZ7C>4P\LJ,GJ.>AZ5KKI]DFH/J"VD O'01M<",>8RCHI;KCVI
M8;&TMUF6&UAC6=B\H2,#S&/4MZD^] '.W7C_ ,-VG@Z#Q5).YTJ=@J2+"Q8D
MDK]W&>H/Y5;U+Q7I&E:QH^F7'F_:-7)%KLA)4X /S'MU%;(L[46RVPMH1;KP
ML6P;1^'2I&C1F5F12R_=)'(^E &)!XHTRY\877AA(Y_[0MK=;AR8L1[3CHWK
MR*JZ;XVTG5-,UJ_M[:\$6D221W"O;X9B@R=@[_I^%=+L0.7"KO(P6QR12A%7
M.% R<G ZF@#D;GQ_I=MX)M?%1T_4'L[EE5(4M\RC)(Y7/ XZY]/6K^I^*+73
M-=T;2GT^\E?52PCECARD6 #\Y[=:WPJA0H P.@Q2T 8%KXD@NO&-[X=&FWB2
M6L"S&Z>+$+YQPK>O/Z'TJIIOC%-2T76]170]1B_LN66/R)(<//L&<H.^:ZJF
MNZ1(SR,J(HR68X % '(WGC5[;P19>(X_#FHSO<L@-BD?[V/<<9(QT_Q'2K^I
M^(9M/\0Z-I<>AWES'J.[?=1J-EM@9^?_ "/QJW/XH\/VHS/K>G1_[UTG^-7K
M&_M-3M$N[&YBN;=_NRQ.&4_B* ,FTURXN?%]]HCZ'=16UM LJ:@P'E2DX^4>
M_)_(U3T[Q-J5]HFLWTGA:\M[BPDD2"U<C==;1D%>._3O[9JYXG\9:%X.M8;C
M7+W[,D[%(P(V<L1UP%!-<;-\?O T1PD]]+SU2U(_F10!T5[XFUF#P99:S;>$
M[J?4+AD$FF@@21 DY)X]O3OS5[4M6U2T\1Z/86N@R7-E>;_M5XK#%K@<9_S]
M*VK6YCO+."ZA),4T:R(2,':1D<=NM<'XV^)5]X4UM=,M/">HZF6B$@GB!"'.
M>!A3G% '1V>J:M/XPU#3)]#,.EP0H\&H%@1,QQE<?G^7O5+3M:\27?A[6;NY
M\,K;:C:RRK96K2C_ $E5'RG/;)KE=!^)'C76==L[67P!<VUC+*J37#EAY:GJ
MV2 ..M>K4 <C>ZOXKC\'Z??VGAN"76IFC%S8M, (@<[CGVX^F>^*OZC>:]#X
METFUL=(MY])G#F^NFD : @<8'?\ (_A7#:Q_PN>?6+M--&CV]AYK?9VRI.S/
M&<Y.<>U;/@?2_B/:ZO+/XNUJPNK%HBJ6\"#<'SP<A%QQGN>M '0V5SK\GBS4
MK6[TJVBT2.)#:7:R O*YQD%>W?MV'7-8DD_B&Z\'ZF_B/3K6RN%O%6!;>3>&
MB\Q-K'K@]?\  5V-_;R7>GW-M#<R6TDL3(D\?WHR1@,/<=:\6U/X0:G8V9U'
M4/&VIWIAEC;RVW88[U'.6/K0![C1110 5BZK_P C%H'_ %UF_P#135M5BZK_
M ,C%H'_76;_T4U &U1110!B>+?\ D7)O^NL'_HU*VZQ/%O\ R+DW_76#_P!&
MI6TX8HP0@-C@D9P: /./&/B/[-XO_LJZ\9IX;MX[-)XBD<;M,S,P;<7!QC P
M!UR:Z?P9=PWFB-+!XE/B!1,P^V%47!P/DP@ XZ_C5'4=$\7736[0:WHZ,L*K
M,9M+,A>09RP^?@=..:VM LM3L=.,.K7=I=7'F%@]K;>0FW P-N3SUYH U:**
M* "FR%UB<QJ'D )56; )[#/.*=10!R>NKKFHVEE:S:(7M9)RU[':7:.6C7!5
M,OLR&;K[ ^M<GX(U*&ROM)NM54:?:MID\5M)<NBH7%P6<*P) .-O'!^4]A7K
M%126T$L8CDAC>,'(5E! /TH YWX?Q21>$8=R-'$\\\D",,8B:5BG'8;2"!Z&
MMS5/^03>?]<'_P#035NJFJ?\@F]_ZX/_ .@F@"GH9NO[ T[:D.W[+'C+'^Z*
MOYO/[D/_ 'T?\*KZ#_R+VF_]>L7_ *"*T* /#?@OJ46D>(?%OA^6XM8;@:B3
M##+)M+X9E.T=^@_2O:LWG]R'_OH_X5Q?C#X2>&O%TLEX\+V&IL=WVRU^5F;U
M8=&^O7WKC/,^*/PRXD4>*="C_B&3*B_^A#_QX4 >SYO/[D/_ 'T?\*,WG]R'
M_OH_X5QGA/XM^%O%92!+O[!?G@VEYA&SZ*W1OY^U=W0!7S>?W(?^^C_A1F\_
MN0_]]'_"K%% %?-Y_<A_[Z/^%9>H^'=/U=-NHZ+I=T/^FT08_F16Y10!D:1H
MT&@6(LM)T^SL[8,6\N+(&3U-8WC?PWXB\2Z?;1:/X@DT6>&0N7@=@)1C&&Q@
MUV%% 'C*:7\;M"<"WU33M:B!Z2LN<>Y8*?U->LV[ZDUK"UQ%;).44R*CD@-C
MD XZ9J[10!YMXQ^(^O\ AK7#IEEX.N]2'EJZW,6[RV)[#"GITJEX?^(OCG6-
M<M+6?P%-:V4T@62XD+J(U[L20!Q7JU% %<&[SRD./]X_X5Y;JM]\:7U:[CT[
M2M(CLQ*5AD+H<IG@_,^>GM7K5% 'G_@M?B;_ &G/)XL;2_L1C^2.+&\/GC&W
MMC/6NOU"+5+C3KF&SF@MKF2)EBGY;RW(X;&.<'FM&B@#Q@_#;XGW.?M'Q%D3
M/'[II!Q^&*[GP5X=\0>&M+FMM6UZ36II)=ZRW#-\@QC:,Y/ZUUU% ',^,/"\
MOC'0'TFXNY+-&D63S;9R&R.Q]1[5Y^G[/.C?\M]5U&<>\H''ITKV:B@#'T/1
MSX>T6UTFQ5?LUJFR/S92S8Z\G%9OB7P/I'B^2WDUS2X+J2W!$;><Z$ ]1\N,
MBNJHH X.W^$W@^UD62+PS8;E8,-\LC\C_>)KLQ]K4 ".  < !C_A5FB@#DM8
M\ >']?OVOM4T#3[BZ?&Z4EE9L# R1C/%5])^&?AG0]4AU+3= LX+R$DQR>?*
MVTD8R 21WKM:* *^;S^Y!_WT?\*\NO/@'X5N[B2<)>0M(Y=@MUD<\\96O6:*
M .$\$_#6T\"75U<:=<7$[W*!&%Q-E0 <\ #K[UTFMZ=?:QHMYIRW/V-KB(QB
MX@<AX\]Q6O10!XI_PI;Q3#_QZ_$&_3/7+2=>W1J]#\':%KWAW0_L6JZT=9N/
M,9Q<3ELA3T7G)/XGO7444 <KXRT_Q=J>CI#X9U2UTR]64,TCC=N3!^7)4XYQ
MV[5PBZ%\<;<C'B729^<Y(7\O]4*]EHH S-,&M)I5JNIFTDOA$HN'B)"%\<D#
M'2N4\;:E\1;*]MAX5T>PO+4QYF:1\MNSTP67C'UKOJ* /(=/\8_%G^T+>"]\
M$6YADD4/(K%0BDX)SN('K7JV;S^Y#_WT?\*L44 >7>(]7^+:Z_=6V@Z#IIL$
M;$,[NIWCU)+C!]L59\)'XK2:XDGB5=)CTW:V^-,;R<<8VY[^IKTBB@"K)]N:
M-U3R48@@-DG:?7I7D4WPK^(-Y(QNOB1=;2<XC,@!_ , *]GHH X?P+X*U;P=
M%>"ZU^XU=KDJ<7+MMC(SDKG)R<\_05N>(="'B?0[G2-10?9;@ /Y4I1A@Y&#
MCU%;E% 'E4/P$\'Q8W6=S+_OWK?T45W6@Z#!X9TF/3-(LX+>TC)*IYC-R3DD
MD\UMT4 9&J:-;ZW"D6JZ7IU[&C;D6YC$@4^HR.*AM_#6FVF/LVA:1%CILMU&
M/_':W:* *^;P# 2#_OH_X49O/[D/_?1_PJQ10!7S>?W(?^^C_A1F\_N0_P#?
M1_PJQ10!7S>?W(?^^C_A1F\_N0_]]'_"K%% %?-Y_<A_[Z/^%8WBHW/_  CM
MQYBQ!=\6=I.?]8M=#6)XM_Y%JY_WXO\ T8M &W1110 5BZK_ ,C%H'_76;_T
M4U;58NJ_\C%H'_76;_T4U &U1110!B>+?^1<F_ZZP?\ HU*VZQ/%O_(N3?\
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MCS8_^>B_G7C7_"-?&F[/S^(-(M/]U5_I&:0_#/XEW?\ Q]^/HTSU\E&_H%H
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M_P#?QO\ XW7LODQ_\\U_*E\J/^XOY4 >-_\ "^YT4&;P-JR$_P"T<?J@I/\
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MPVG_ #ZP?]^Q0!Y)_P -%:#_ - +6/\ OA/_ (JC_AHK0?\ H!:Q_P!\)_\
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M/[2U[_H7T_\  Y?_ (FC^TM>_P"A?3_P.7_XF@#;HK$_M+7O^A?3_P #E_\
MB:/[2U[_ *%]/_ Y?_B: -NBL3^TM>_Z%]/_  .7_P")H_M+7O\ H7T_\#E_
M^)H VZ*Q/[2U[_H7T_\  Y?_ (FC^TM>_P"A?3_P.7_XF@#;HK$_M+7O^A?3
M_P #E_\ B:/[2U[_ *%]/_ Y?_B: -NBL3^TM>_Z%]/_  .7_P")H_M+7O\
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M -NBL3^TM>_Z%]/_  .7_P")H_M+7O\ H7T_\#E_^)H VZ*Q/[2U[_H7T_\
M Y?_ (FC^TM>_P"A?3_P.7_XF@#;HK$_M+7O^A?3_P #E_\ B:/[2U[_ *%]
M/_ Y?_B: -NBL3^TM>_Z%]/_  .7_P")H_M+7O\ H7T_\#E_^)H VZ*Q/[2U
M[_H7T_\  Y?_ (FC^TM>_P"A?3_P.7_XF@#;HK$_M+7O^A?3_P #E_\ B:/[
M2U[_ *%]/_ Y?_B: -NBL3^TM>_Z%]/_  .7_P")H_M+7O\ H7T_\#E_^)H
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M2W1Y]3M[194>0L,^8H.4CP005]3D\4 =O10"" 0<@T4 %%%% !1110 4444
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M+>W+, ZMMSU('&>U;NB:)9^']-6QLA(4WM(\DKEWD=CEF9CU)-:-% !1110
M4444 %%%% !4%[96VHV<MG>0I-;RKM>-QD,*GHH HZ;H]AI,<J65OY?FMND8
MNSLYQ@99B2<#WXJKI_A?1]+U&2_L[9X[J08DD,\C%^,#(+$' Z9Z5L44 8Y\
M*:$UK]F.F0&'[7]NV$''GYSO^N?PJ:XT#2KHW#3V4;M<2I/*QSDR)@(V>Q&!
MR*TJ* &2Q)/"\4J!XW4JRL,@@\$&L[3?#NE:1.9[*T"3%!'YCR-(P7^Z"Q)
M]AQ6I10!3GTJQN=2M=1FMD>\M ZP2GJ@; 8#ZX%5K7PWHUE:P6UMI\,4,%P;
MJ)%SA93G+#WY/YUJT4 8LOA/0YH3";!5C+NY6.1D&7.6'RD<$\D=/:MB.-(8
MDBB14C0!551@*!T %.HH *CG@BN8)()XUEAD4HZ.,A@>""*DHH S=+T#2]%+
MM86@B=U"LY=G;:.BY8D@#TZ4^;1--N+^6^ELXWNIK8VLDAZM$23M/MR:OT4
M9MOX?TFUALH8+"%([&-HK9<9$:,,,!]1ZU6/A'0C';Q_V>GEVZA(XP[;-H.0
M"N<, >@.0*VZ* "BBB@ HHHH **** "BL#Q)XCG\.VSW9TB>[M(PN^6*:-<%
MF"@88@]2/SJ:'5M0>^LK>XTN.T%P9-XEO$,BA0""JKG?G///% &S6/=^%M'O
MM434[FV=[R,Y27SY!LZ#@!L#.!G'7O5E-<TF23RTU2R9Q&9=JW"$[!U;&>GO
M4L>IZ?+8-?QWUL]FH)-PLJF, =?FSCB@#//A/1?[2FU!;1TNIY!+*\=Q(N]Q
MT) ;!Z#M5Z_TJQU3[/\ ;K9)_LTRSP[OX)%Z,/S-$6JZ=/:K=1:A:R6[OY:R
MI,I0MG&T'.,Y[4^UU&QOH7FM+VWN(HR5=XI5=5(Z@D'B@"LGA_28QJ02QB4:
MF2;S /[XD;3G\*AN/"VBW4OFR6*B41I%YD;LC;5SM&5(/&2,^AQ4W]MV5SI]
MY<Z9>65Z]O&S%8[E=H(!(#,,A1QU-(NNV$%E!-J-[8V<LD*2NCW2;5W>C'&1
MG(![T 6[*RMM.LX[2SA6&",85%Z#_$^]6*PM3\6Z1I.KZ9IUU=PH^H*[)(TR
M!4"KD$Y/0]!ZFMT'(R.E !1110 4444 %%%%  1D8K&LO"FBZ?>S7EO9L)YU
MVRL\TC^8,8PP9B#QQS6S10!DZ=X8T;2;E;BRLECE12D9+LWEJ>H0,2%'L,5/
M-HNG7&HG4)K2-[MK<VQE/4Q$Y*_2K]% &;!X?TJVL+&QAL8DM;&026T8SB)A
MG!'OR?SJJ_@_0'<L=-C 9S(R*[*C$G<=R@X(SS@C')]:W**    8 P!1110
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MR;_KK!_Z-2MNL3Q;_P BY-_UU@_]&I6W0 4444 %%%% !1110 4444 %%%%
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M\ _]#);_ /?N3_XFK'_"K? W_0LV'_?!_P :/^%6^!O^A9L/^^#_ (T 5_\
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MI_@RYT9+%M+U<13V]D+&5Y;8.LJ!BRL%##:P+'U'/2I(_!<4&MS7T<EFZ3W
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M<4$B7 8N'\]SAO7!;'Z537P[?W6J6%[JNK)<G3R[6ZPVHB.]E*[G.YL\$\
M9/2@#)BU/4I_%*Z+'K4T\=Q;7'G&:T%L87& IA) +X).?O8&#GUWO"&J3:QX
M4T^]N#FX:/9,?5T)5C^)4FJ<^A:DUW:ZIJ-^NH2Z8DDEI!;VPA,DA0KEB6.3
M@D8&T9-7?"6E2Z+X6T^QG_X^$CW3<YQ(Q+,/S)H VJ*** "BBB@ K%U7_D8M
M _ZZS?\ HIJVJQ=5_P"1BT#_ *ZS?^BFH VJ*** ,3Q;_P BY-_UU@_]&I6W
M534M/BU2PDLYGD1'*G=&0&!#!@1D'N!5#_A'I?\ H/:Q_P!_D_\ B* -JBL7
M_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XB
MC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W
M^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I
M?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'
MI?\ H/:Q_P!_D_\ B* -JBL7_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_X
MB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I?^@]
MK'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'I?\
MH/:Q_P!_D_\ B* -JBL7_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:
MHK%_X1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I?^@]K'_?
MY/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q
M_P!_D_\ B* -JBL7_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_
MX1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I?^@]K'_?Y/\
MXBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_
MD_\ B* -JBL7_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7
M_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I?^@]K'_?Y/\ XBC_
M (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_D_\
MB* -JBL7_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:
MQ_W^3_XBC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I?^@]K'_?Y/\ XBC_ (1Z
M7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_D_\ B* -
MJBL7_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^
M3_XBC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/
M:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_D_\ B* -JBL7
M_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XB
MC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W
M^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'I?\ H/:Q_P!_D_\ B* -JBL7_A'I
M?^@]K'_?Y/\ XBC_ (1Z7_H/:Q_W^3_XB@#:HK%_X1Z7_H/:Q_W^3_XBC_A'
MI?\ H/:Q_P!_D_\ B* -JL75?^1BT#_KK-_Z*:C_ (1Z7_H/:Q_W^3_XBG6_
?A]8;^WO)=2U"Z>W+&-9Y%*@E2IZ*.QH V**** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>graph.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 graph.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!E +P P$1  (1 0,1 ?_$ *0  0 " @,! 0
M       %!@0' @,( 0D! 0                     0   % @($!! + P<'
M"@4% 0 ! @,$!081$B$3% <QT5,502*2HN*#HU1DE+0E%C9F"/!18>$R(Y/3
M51<G<8$8D4)2,R0T5J%B<M)S-2BQP;)#=.1UI3<XPF.SP\3Q@I6U=B81 0
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M^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?>
M'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=
MWD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6
MV)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?
M> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^
M&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> '
MY6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=W
MD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V
M)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?>
M 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&
M=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y
M6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD?> 'Y6V)^&=WD
M?> 'Y6V)^&=WD?> *_?M@VG2K3G3X$'4RV=5JW-:\K#,\A!Z%K4GZ*CZ "P;
MK?42F=O\H< 6H
M
M               57>EZB5/M'E#8!NM]1*9V_P H< 6H
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MA+ !,>[7=E;K-FU"DU^4[-K=M5*1394N0M3KKB4JS(4M:^F498J3B?Q -M@
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M#%W [J7HT=MAU$FE.)6TDD&2WHAK=5TN&E:RS*/HGI >GJK_ +KF?[!S_H&
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MU(=?-6&/R+2 WL      *KO2]1*GVCRAL W6^HE,[?Y0X M0
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MZTRFBU*LV^BG6W7WVHT&:4S72V52_P"Z'-BZAM#1.Z"/(^YE49$?Q@+^
M
M                                           "J[TO42I]H\H; -UO
MJ)3.W^4. +4           "N;R*/-K5@7'28)&J;.ITIB,@CRFIQ;2B2G'Y3
MT -=5^ZJ)>MH6Q;% E-RK@D3J6Y.I25$<F BGOMO2U36?IL$UJ30><BQ49$6
MDP&Z  !YUW 3:[>D^]F*Q<M9-VEU4]G)N:LDI:?4X24))9+RI2;)X)3@1?$
MW!Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL #T
M]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1US
MQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8
M'H![1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#V
MCKGCO8 'H![1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'
M>P /0#VCKGCO8 'H![1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >
M@'M'7/'>P /0#VCKGCO8 'H![1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.
MN>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL #T ]HZYX[V !Z >T=<\=[
M  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL #T ]HZYX[V !Z
M>T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL #T ]HZY
MX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL
M#T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![
M1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGC
MO8 'H![1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ [MW,V7-LRG29
M;RY$A9.DMYQ1J6K*\M)8J/2>@B 60   %5WI>HE3[1Y0V ;K?42F=O\ *' %
MJ  &!1*[2JY3RJ%+?VB(;KS!.Y5H^LCNJ9=3E<)*NE<;47!IZ&@!G@
M      /*_NF2W$[S]X$,C5JWC4\HB/I<S4MQ*<2^/ZT\/W@/5
M
M                            JNZWU$IG;_*' %J   !5=Z7J)4^T>4-@
M&ZWU$IG;_*' &7>GI[S4WZ$\U<[:Y.MYZVC9]1E5FR[-T^?-EPZ&&("D_P#%
M/[#?^;@+3NMMFN6U9<6E5UR,Y5B?F29:X)N*CYI<MV1@V;J4+P(G<-)?R@+8
M         I]#WB/5QY1TVV*L]3T37H"ZH:Z8A@EQGU1WG,BII2,B5H,]#68R
MX" 7   >,_=NC(3[QE7)U]QI2&JBZTVVK*ETUNIZ1POYR20LUX?TDD?0 >S
M
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M4\X26%F1F6&*4((P'O2EQV(U-BQH[JGV&&4--/K7K%+2A)))2E_SC/#28#)
M
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M)<6;BG%..$9HZ5.52S(D] M "S
M
M   *KNM]1*9V_P H< 6H   %5WI>HE3[1Y0V ;K?42F=O\H< 6H^ P&C+(JN
M^ZT;?:H$;=4F5%B.OG&D)K=/86MMQU3B3=3];F=P5TZ\>F/3@0#;UK5&O5&A
MQYE>H_,-5<S[12MI;F:K*M24?7M$2%9D$2M'!C@ E0    'Q:B2DU'C@DC,\
M",ST?$18F8"#@UNC71$FP6F:DTRIO5R-JA5*E*-#I&D]4[(:BKS?*VK%/R:
M&IZ8PQ:=N[YV[;CHI[=+6HZ>S'(FTM&FD,F2DX=$E=-CT3T\("9ONG4^D;L[
M,?I32&7Z14:)S4MLBS)U[[3#I),N'6M.K)?]+'2 VX  /'_O$PGG-S5F3E,X
M-1:A*CI>S$>)R#=7AAPE_4 -R;@;4HEJ6@A%!6Y-<K+<:JS&GY3*UM')CH6@
MB;0E.1.0RPS%B?Q@-H;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$
M;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5
M/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEW
MCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:
MJEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX
M@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>
MZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54
MN\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$ ;54N\>ZIX@#:JEWCW5/$
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M_P"ZNXZA<=B4VJU%U$B8O7,/3&DDAN0<9];!2$)3TI)>)O6%ET:=&@!;
M  !U3&'7XKS+4AR(XXA2$2F2;-QLS+ EH)U+K>9/"69!E\9& I]"W8,4JI56
M8[7ZG5&ZZLW*S!FHIQL2E&P4?%9,0V%IP;218(6DM&G'2 ^TK=93(+M+1(JU
M2J=+H;FMHM'FKCKC1EH(TLJ)3;#4ATV$GE;U[J\O#](B,@N@  \T[[*?M7NP
M0W\,=@GMR,?BS2GF/_O .'N<6Y:;%*>N8J@L[GGZ^FKI[C[>74,*;=-;3.!.
M'HR8F9GA\F(#TR
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MGT$E71X# >PP
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M%-Y;K5<0!SQ3>6ZU7$ <\4WENM5Q '/%-Y;K5<0!SQ3>6ZU7$ <\4WENM5Q
M'/%-Y;K5<0!SQ3>6ZU7$ <\4WENM5Q '/%-Y;K5<0!SQ3>6ZU7$ <\4WENM5
MQ '/%-Y;K5<0!SQ3>6ZU7$ <\4WENM5Q '/%-Y;K5<0!SQ3>6ZU7$ <\4WEN
MM5Q '/%-Y;K5<0!SQ3>6ZU7$ <\4WENM5Q '/%-Y;K5<0!SQ3>6ZU7$ <\4W
MENM5Q '/%-Y;K5<0!SQ3>6ZU7$ <\4WENM5Q '/%-Y;K5<0!SQ3>6ZU7$ <\
M4WENM5Q '/%-Y;K5<0!SQ3>6ZU7$ <\4WENM5Q '/%-Y;K5<0!SQ3>6ZU7$
M<\4WENM5Q '/%-Y;K5<0!SQ3>6ZU7$ <\4WENM5Q '/%-Y;K5<0!SQ3>6ZU7
M$ @=UOJ)3.W^4. +4   "J[TO42I]H\H; -UOJ)3.W^4. +4 U:][P%)4^[S
M1:%UU^GH6IMFKTJE&_"?R*-*E,.FXC.DE$98X= !?;6N#T@H<>K<VSJ1M&?S
M?56-FEMY%J1]8UF7ES9<R=.DC(P$J      .J8F6N*\F&XVS+4A1,.O-J=;2
MO#I5+;2MI2TD?"DEIQ^,@%'MFP[RH]9KU0>N.$\5Q/;3,*-2W&'6GTQDQVU1
MUNS92$DG5I49.-KQ/$!D*L>Y*M4:0_=E<BU&'19"9T6' @+@:V8TDTM.R%N2
MIAJ2WF4HD()!9N'$BP 74  5+=FTA[=_3VG"Q0XF0E9?&2GW",!Y%W",6W4J
MK<>ZV[&W$TNLF4C;6WB85'?I&M=49FHC3E4WFQ-7!EX-.)![.LU%M-6O3(UL
M2F9E"AL(BP'X[R9#9ML%JR+6I-1*,LN!Z>$!,@
M
M             JNZWU$IG;_*' %J   !5=Z7J)4^T>4-@&ZWU$IG;_*' %J/
M21@-*VS;/O*VS244:EN6:NF1W'50D2551:VFG'%.)9)2$-XI;S94XECAPF8#
M:MK>E7,<?TKV'G[I]KYJUVR?35J]7K_K/ZO+FQZ./0 2H            "J[
MK?42F=O\H< >-*;2X,;WG)E$GH-5.G5RH4QYLC-)JCU(WHV7$L#+,W(PT /8
M>ZVB[OK>H3]N65.9F1:;(<*<EN2B2ZW(</IB>-)]*KI<,,"X %R
M
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MDHB7JU-&HLQ'EX0&^TJ2I)*29*2HL4J+21D?1(!]
M
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M2H4:0W*I<ALE0WV3Q;4V6@LO[,,,.@ S@
M
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M0990V6 ^+)1I,D&1+P/*9EB1'T,2Q+'^4!6'ZQ5K6HE3KMZ5B _3(+.N-R#
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M4G+AP'B1!MG=?.M^90I#E#M&79L5,E25TV;3FZ6XXYJT&;Y,M&:5),C).?\
MS<.@ N         "J[K?42F=O\H< 0'O'T_;MRETLX8FW':D%\FSR&WC/^1
M#6/N=;SYE3I[N[Z5';2W18KDR!*0:M8MMR4:G4N$9F1Y5R"RF6&@!Z7P+A^(
M!0[!;WN-W/="KT?AN6^<C&VRCDV2DLYE_P! B7ER9<=;BK-P'@ O:5)6DEH,
ME)46*5%I(R/@,C ?0
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MRSJ(S5@HSRGA@0"_65Z?\V.^G'-/.FN/4<R;3L^HRIRY]JZ?/GS8X:,, %@
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MVO9]3J4@VY2W(U/D/)-U:C-S.XMPT%@AM*WR(OB(R^(S ;,
M
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MUX!YY\'Z\ \\^#]> >>?!^O ///@_7@'GGP?KP#SSX/UX!YY\'Z\ \\^#]>
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M7AD4KIN#3_-(!L-*DJ22DF2DJ+%*BTD9'T2 ?0
M
M     57=;ZB4SM_E#@"U    JN]+U$J?:/*&P#=;ZB4SM_E#@"(WTME+H5&H
MTEU;%'K=:A4ZMN-K-HSAO&HU-*66!I2\M*&CP,OI ,Z=N:W2R:>]#=M&D-,N
MMFVMUF&PR\E)EAF2^VE+B%%_2)6/R@/FYJIS*ENXI,B5(5,4WM$9F:XK.M]B
M-)<88>4K^<I;3:5&?1X0$M=] KE8A(31+@DV[4F#4;$MAIB2THU%A@_'D)4E
MQ)=# TF1]$!4)S7O+M2W&Z=(LV7"09$S)E,U2.\LL"Z9;3;CZ$'CT"68"1HE
MM[UIL^%4;NNB+%98)*GK?MZ+JHSCK3V="G)LLWI*T*06"T)2V1\'QY@O@  X
M2)#$9AR1(<0S'92IQYYQ1)0A"2Q4I2CP(B(M)F8",HMWVE74R%42MP*HF(25
M2E0I3,@FB5CE-S5*5EQRGAC\0#%I>\.P*M.:I]*N:E5">]CJ8D6=&>>7E2:E
M96VUJ4>"2,SP+@ 6   57=;ZB4SM_E#@"U /SX]Y.G[!OMN=LBP2Z\S(2?QZ
M^,TZ9]4HP'O"SJF=5M&AU0U9CGT^+)-7#CKF4KQZX!+@   K5^;NK2ONEL4R
MYH9RXD9],EDDN.,J2XDC3])M258*2HR,O^? P$+^:5,A;U8>[!FD2B=7"U[=
M021;.A"&C6E.'#DRHR9_Z6"0%T9K%)>J3]+9FQW:E%2ER5!0ZA3[2%_14XT1
MYTDKH&9 ,L
M                                    57=;ZB4SM_E#@"U    JN]+U
M$J?:/*&P#=;ZB4SM_E#@#YO,ET1NV%PJ[0)]QTFJ.HA3(--BKF.(0O%6O6AH
MTN)0V:,<Z.F2K#+I :KMBUMT-WR2A4W>C<=4C/N.,*M276G6"=:01FY&.&^V
MS+4R3>*3P_FD?3:# ;VIM-@4RGQJ=3V$QH,-M#$:.V6"4-MEE2DOV$0#)
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M]U3Q &U5+O'NJ>(! [K?42F=O\H< 6H   %5WI>HE3[1Y0V ;K?42F=O\H<
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M>NIL>HG#2RU(RY$R#3$C1-:ZE)F25.FK+B9ETVD!;0 !5=UOJ)3.W^4. +4
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M:$Y34K21GCT5 W?M;W47+<YWH]$=H*I.-M)CDV2TLYUZ.D(E9<F7'6F:L?D
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M7ZR+/IEG6S#MVF.O/0H6LU3DDT*</6N*=5CJT-((LRSP)*2(B 3@
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M5G>4E)$:U8$691EPG@6&D!S)*4FHR(B-1XJ,NB>!%B?[B ?0
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MU8U$P3V11))HT*E)R$DNGS9>FX, &H3HGO?3,5/W%LYETN&TL-Z/C^H09?\
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MKJ#++JB2A9HZ4^FQ,L>AP=$-4EOH]ZZ(65ZU42#1TRE<W/+Q+AP^I<(C_=I
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M2VZ>RA1J5])1F39:3Z)@)B)(MZ&G+$;:CIPRX--9"P+H=*D@&1SQ3>6ZU7$
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M/=K6W&J+3*_<#=5M^@/-2(,1,(X\EY<7^Z;;)VAU#I-:%'D9;S*(C/1H,+^
M *KNM]1*9V_RAP!:@%.WP6-)OG=U6+9B.ML3)J&U17GL=63K#R'DDHTDHR)6
MKRF9$>&(#SA;&]+>]N-8BVQ>=N'+MF.I2(;R2))I):S<,F);>9IS2HU9%]-T
M,4@/0V[W?7N[OQ"$42II145%BJDR\&998%B>#9F9.8=$VS40"]
M   ,>=3J?4(YQY\9J7'5])E]"7$'^U*R,@&-1;;MVA-.M42E0Z4T^O6/MPF&
MHZ5KPPS+)I*24>'1,!(@-)N>Z#N?<F.R3;J!)=4I6SE*P;3F/'!/29\"Z&*C
M 2=)]UK<Q39<:6BCNR'HRR<1M$E]:5*2>*<Z"4E"L#Z&&'Q@-L@(RO6O;=PQ
MVXU>I<2JL,K)QIJ8RV^E*R_G))PE8'T/V (YC=GNXCD91[4H[)&>)DW3XJ<3
M_<V0">AP84)DF(<=N,P1F9-,H2VC$^$\J2(@'<
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MH)?2:OD(!N_=U[P&[>^B:CP*@4"KKP(Z3/P9>-1]!H\3;=^3(HS^,B ;'
M
M                           %5W6^HE,[?Y0X M0   *KO2]1*GVCRAL
MW6^HE,[?Y0X M1XX:.$!YWL^^H,*^:16+FOUU,VI1JJFY*!4)[4:#3949UIM
MF.B$>KU2DEG22EXFYE-1<)@-K;GYU0G;OJ;,G/OR3?7*7#E2S6I]V&<IW8W%
MFX9K//'R*Q5I,@%R      '7)DQXL9V3)<2S'80IQYY9DE*$(+,I2C/@(B+$
MP&J[3O:\ZI>M0<FR-30JA0W*Q0J4;+25L,E(U,=UQ>4W%./-IUJDJ5@G-EPT
M .>Y^YD7)3*).D[PEUBNO0D2JG;J%T;!"UMD3A+9C16Y2$MK67_6%@>!'CP
M-J@ "H;L)49%C4U*WD)46OQ2I1$?]X<^,!:=MA\NWU:>, VV'R[?5IXP#;8?
M+M]6GC -MA\NWU:>,!P?>IDAE;#ZV'F'4FAQIPT*2I)Z#)23T&1@-(;Q?=9W
M9W(;LVWY"+9JRL5%LYI7#6KAZ:.:BR=K-)%_1,!KIJ\/>'W*N)8K2$W3:K1Y
M4O*<.4TE!?T)*2U['Q$3J<I=!(#<N[_WF=V%W-I:?G)H%3PQ7"J:DM),R+3J
MY!GJEE\6)DK_ #0&PX]V6K)+&-68+Y8$>+<EE>@^ ^E48#/VV'R[?5IXP#;8
M?+M]6GC -MA\NWU:>, VV'R[?5IXP#;8?+M]6GC -MA\NWU:>, VV'R[?5IX
MP#;8?+M]6GC -MA\NWU:>, VV'R[?5IXP#;8?+M]6GC -MA\NWU:>, VV'R[
M?5IXP#;8?+M]6GC ?#G02(S.0T1%I,S6GC 1\F\+2BX[56X#&!8GK93*-'Q]
M,H@$5*WM[K8N)/W?1DJ(\#04^,I1&>G2E*S4 AY7O#;EXIX.77$5PE]43KW!
M_LT+ 0TOWKMR#!'JJT]*P+'!J%++$_B^M;;T@(>7[Y6Z1@SU3%6E8&6!LQFB
MQQ+H:UYO@ 0TKWW+)2?]DM^I.EB>EU3#6CH?16Z B'O?@)Q1-P++6ZXHNESS
M].;_ $$1E8_R@.A7O:[T9N)TJPR,C(E)Q1+D=+P&?U:6\=(#C^??O03S/9+(
M:C(S=*:J;-29DKZ.*GGLI_M(@'STX]\>41.,TYIA):#3J8"#,_CP>6:@'STM
M]\[O5O[.E_ZP#N:O7WR&4*UE,CO=',M%/Q(OB(FW4_\ ( Z?S,][W\#;\59^
M\ =C&]#WNFUYEV\P\6&&1<5LB_;TCJ#_ ,H#@K?3[UB5&D[2:Q(\#PI[YEH^
M(R>P $;[/>J2M*CM!I9$9&:3I\C _D/!XC ?7?>&]YQIPT*L!DU%PFFE519?
MN4F09& X_P 17O-?X ;_ /XBJ_?@.QSWFM_C&5$C=^2'#(C,E0:BC'Y2(U<
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MC+JULUBNU>/4K?OE4E,2DMQ$1UTQ;;+DJ.E#R5&M]*FF5)7K-)'AACP@-Q
M   /BTDI)I/'!1&1X&9'I^(RP,@%0JFZ^B3K?J%$34:Q'C5,FTRG5U*5.<R-
M+)>1)5)<YM*5_1<(D=.G0>@!!Q[&O*!O+.OHK-0JT)BB*CMKEG2V4OR"?-:8
M;FSPVUH;,L%YTHQ(_P"<9=* [*S!N>\JU:RW;;DVZBA5!%4E5*>]!=7E;;4A
M46*F%(E*5KS7@LW,B226.D\" ;(  %0W818R[&IJELH4H]?BI22,_P"\.?&
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M0;ZA/$ ;%#Y!OJ$\0!L4/D&^H3Q &Q0^0;ZA/$ ;%#Y!OJ$\0!L4/D&^H3Q
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M3JB* I1ZI]Y$56;5./Y#6?3X&2]!%H(@VN             JNZWU$IG;_*'
M%J
M                                        %5W6^HE,[?Y0X M0   *
MKO2]1*GVCRAL W6^HE,[?Y0X M1Z2,!I6V;9]Y6V:2BC4MRS5TR.XZJ$B2JJ
M+6TTXXIQ+)*0AO%+>;*G$L<.$S ;5M;TJYCC^E>P\_=/M?-6NV3Z:M7J]?\
M6?U>7-CT<>@ E0     !"WI<?HS:57N#9]KYJB.R]ESZK6:I)JR9\J\N.'#E
M,!AT^X;G9A2*I<U-IM+HT>(N6Y*B5%^8XE*$DL\S;D&&DDDC,9F2SX.#X@AF
M=Y=:931:E6;?13K;K[[4:#-*9KI;*I?]T.;%U#:&B=T$>1]S*HR(_C 7\  5
M7=;ZB4SM_E#@"U
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M:DT'G(L5&1%I,!N@  5"-NVB1&4L1*Y68T=&.K89EDA"<QFH\J21@6DP';Z
M>T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL #T ]HZY
MX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL
M#T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![
M1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGC
MO8 'H![1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'7/'>P /
M0#VCKGCO8 'H![1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]@ >@'M'
M7/'>P /0#VCKGCO8 'H![1USQWL #T ]HZYX[V !Z >T=<\=[  ] /:.N>.]
M@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL #T ]HZYX[V !Z >T=<\=[  ]
M/:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL #T ]HZYX[V !Z >T=<
M\=[  ] /:.N>.]@ >@'M'7/'>P /0#VCKGCO8 'H![1USQWL #T ]HZYX[V
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MUJ=7J=0X\.O5CGZJMY]HJNS-P];F6I2/J&C-"<J#).CAPQ 2H
M       Z(M0@2UR&XLEJ0N(YJ)2&EI6;3I))9MN$DSR+RK2>4].!D [P
M'1,J$""AMR;):BH=<0PTMY:6R4ZZHD-MI-1EBM:CP2GA,P'>          .A
MNH0'9CT%J2TN;&2AR1%2M)NMH=S:M2T$>9)+R*RF9:<# =X
M         Z&ZA =F/06I+2YL9*')$5*TFZVAW-JU+01YDDO(K*9EIP,!W@
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M:%%=-Y#"G77'<B6DJ=D.J>=-MI'2--YW#R(3H26C3P@)X
M    '5*1(7%>1&=2Q)4A1,O+1K$H698)4:,49B(].&8L?C 4:QK"O*UB-M=?
MIM11*D'*K$MRER$SYCBM"EKD'47$)5E(DIP:RI(L"3@ Y3-W=>:EU]% K[5,
MI-RN'(J45V#M+[3[K9,R'8;Y/L(;-U"4G@XTX1+Z;HX ++$M2C1;3;M1MHSH
MS4$J:3*SS&<?5:G!1]$S3PF HKNY:>[8#%M*N1::JW(4\[7DQ2SN(7%5!4A3
M)NJTG$5J\V?A(E8= !:Z]8T*K3[;>4M"(-ON/J. MHG&WVGX;D/5'BHB2DDN
MX_1/'@P 1E'L6[K?IJ*50;E9*EQENHI\*IP%34LPW,#;84M$J,ZLV#(TMJSD
M6K/*I*C(E$$W8MH1+1MF+0HKIO(84ZZX[D2TE3LAU3SIMM(Z1IO.X>1"="2T
M:>$!A[TO42I]H\H; -UOJ)3.W^4. +4
M
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MQ=5+4V<TEN26W-5DZ3(:L^)8ZOHF&R@
M                       %5WI>HE3[1Y0V ;K?42F=O\H< 6H
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M4Q6Y,&8[2:C04TQF9$BR)B$2FYVM-#Q1D.J9(T.D9+61(T'IT -B@
M                                             *KO2]1*GVCRAL W
M6^HE,[?Y0X M0
M             "$K]HTVN52AU*6X\A^WY2IL-+2DDA;BVE,F3I*2HS3E6?T3
M+2 FP
M    57>EZB5/M'E#8!NM]1*9V_RAP!:@
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M?+H 5.A;S'ZU6)M+C6G66WJ9);AU1UU=*)N,XZA+I&O+/6I:2;<)1ZI*OY=
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M8X$>(#,N6])%$5*-JW*M5H\%DY$R5!1%)M"22:S2C:I$9;RB2G'!E*_B^EH
M=43>!3YE:M^+%;UM)N> [.I%5)2DDM;)(<-E3*T)4DU,N9TF9X]*HC26 "U
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MB6[1Z19VZ:XX$<FJ]+E4EB;5<35*?8FQ5)=9>>,S<<:(L"0A1Y4$E))(B(B
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M:4E*7&GF:2[&9R](DT*0ZE18=-CB IU"LNJ7?>-TUU-<;.93JC2U4NMQHA%
M5/IK+J)"$Q5/N*<:2B3JE_7YL^."RPP()^VF:W,WW3)<VI1JJ=&H9T^HOP(J
MHD5J1)E)>:CFE;\M9O$VVI:\7-!&G0G'2$GN0]6:OJ_[KZ05C9,/HZK;7/H_
M)FS -A *':KV]U6\6XF[CCQ$60E/_P#S[S*FS=,R6G)B23-S2WFUF<OI?1T
M/MKO;VU;QKA;N&/$18Z4>8'FE-FZ:LR<N))4;FE&;/G(NFPRZ "UWM[:MXUP
MMW#'B(L=*/,#S2FS=-69.7$DJ-S2C-GSD7389= !:[V]M6\:X6[ACQ$6.E'F
M!YI39NFK,G+B25&YI1FSYR+IL,N@ M=[>VK>-<+=PQXB+'2CS \TILW35F3E
MQ)*C<THS9\Y%TV&70 ^6N]O=5O'N%%PL1$6,E'F!UHVS>4O,G+B25&YI1FSY
MR+IL,N@ M=[>ZK>/<*+A8B(L9*/,#K1MF\I>9.7$DJ-S2C-GSD7389= "Y57
M_=<S_8.?] P&I]V=E5NX=W=C'7*NPY;]/C0*C%I4.&J.\MV.E*XZ9,ER1()Q
M#:BQ,FVF\QX=#081].J=+BTZZ($ZF)K#E9OF33X5-?=4Q$=?<0VI)2UDEPM2
M24*,TJ;7F,B+(9@(9VH5*B4'>= @(C42%!F4E+T&AR5/Q8#4K5MU!4=:689M
M*U1&M>#:<BL3^4!<MXU*MFT; K!V5'AT:9)8AE+33W"AXP%RD-.R5FP2LN5I
MQ>,G(I22TXG@ Z*1:<ZB5>=)ATZ@VW29= E(?HU&G.2#EJ:RFQ,U*H<)/U25
MJ0ITL35G(CZ "M6[2;:A;N-V=?MO4KNJ5,I,553;<UDM\E$3<Z*ZZ1ZQQIEE
M*R-I1Y6TH+ BRD FXE&M*MT>_J[>+4=ZN4RH5!A51E93D4Z/&+&"45Q2LT8B
M;-+J#;-.*U9N$!>*++N&9NBBRJD2RK[]#)R1B6#FTJBXXF704:N'Y0%$J<>-
M)W%;NXS2W6H[\FV6C<9<4RZ25NLI5E<:-*D*TGTR3(R,!-1:+"MW>;6*7;$-
M5,BSK;3-7 I*(S)G,:E+:0\RT_EB$\:%Y<SA93P+-H 9U ]..>8FW>EVR9_K
MN</1+9<N'_7;#_:<O^RZ8!$;TT[/1H%XQ[@5<$%FIPY-+MZ1LKD"4MUXFVVX
MJH;<=YUU&?.R;KCJ2-.)I/Z20MMYTE-?@U.-'NZ11FXD9;-3CQ50S9;-;>LS
M2U+:.4T1MJ(SU;[1Y-)*3](!KV)5#JEN;FIK<!JFR7*JA$>'%2I#28S<.2VI
M3*5FI1-+:22RS&9X&6D^$!O$        !5=Z7J)4^T>4-@&ZWU$IG;_*' %J
M                              $37+0M.OJ977J+ JRXY**.J=%9DFV2
M\,Q(-U*\N.!8X ,DJ)1B?)\H$8GTQ]B2[J6\Y1<<=02L,=5C_,X/D "HE&*+
M#B% C;)3E-KI\?4MZN.IDLK2F4896S06A.7##H *))W4UMRC5:V6:_'1:]:D
MR7YK;E/-VIFB:Z;TA!352=2:C-2DH<7&4:4X<)EB M\FR[1ERH\V;18,V=%:
M*/'FR8S3TA#22,B03KB5+PP4?1Z)@,UBC4B/):E1X,=F2Q'*&R^VTA*T1DF1
MDPE1%BELC(CR%H 1MX6HW<42"E,@X<ZF3H]1I\PD:S5NQUXF1HS(S)<;-;:B
MQX% )--'I*6YC:84<FZBI2Z@@FD$F0I:";4IXL/K#4A)),U8Z"P 9$>.Q'8;
MCQVTLL,I2VRRVDDH0A)8)2E)8$1$18$1 (^N6Q;5?:::KM)A59IA1J9;G1VI
M*4*,L#-).I623,OB =JZ#0G*/S*Y3HJZ-JR8YL4RV<75)PRMZDTZO*6&A.&
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M.W^4. +4
M
M          *KO2]1*GVCRAL!K^UOS8YAB\P_[IZ?9O[GRBL_];T_T\W" E?U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /UV^'-X!^NWPYO /U
MV^'-X!^NWPYO /UV^'-X!^NWPYO 15T_FQS%)Y^_W3]7M/\ <^43D_JNG^GE
$X '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139936750404752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Anika Therapeutics,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000898437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3145961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">32 Wiggins Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bedford<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">457-9000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ANIK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>f8k_110122_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="anik-20221101.xsd" xlink:type="simple"/>
    <context id="From2022-11-01to2022-11-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-11-01to2022-11-01">0000898437</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-11-01to2022-11-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-11-01to2022-11-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-11-01to2022-11-01">2022-11-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-11-01to2022-11-01">Anika Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-11-01to2022-11-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-11-01to2022-11-01">001-14027</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-11-01to2022-11-01">04-3145961</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-11-01to2022-11-01">32 Wiggins Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-11-01to2022-11-01">Bedford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-11-01to2022-11-01">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-11-01to2022-11-01">01730</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-11-01to2022-11-01">(781)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-11-01to2022-11-01">457-9000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-11-01to2022-11-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-11-01to2022-11-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-11-01to2022-11-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-11-01to2022-11-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-11-01to2022-11-01">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-11-01to2022-11-01">ANIK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-11-01to2022-11-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-11-01to2022-11-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04
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MYHOA/UY_ 5!+ 0(4 Q0    ( "^*854'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ +XIA5<-*^@OM
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ +XIA59E<G",0!@  G"<  !,              ( !RP$  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  OBF%5Q*R@_TX$  !_$
M&               @($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ +XIA59^@&_"Q @  X@P   T              ( !D P  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    "  OBF%5EXJ[',     3 @  "P
M        @ %L#P  7W)E;',O+G)E;'-02P$"% ,4    "  OBF%5JL0B%C,!
M   B @  #P              @ %5$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ +XIA520>FZ*M    ^ $  !H              ( !M1$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ +XIA5660>9(9 0
MSP,  !,              ( !FA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      D "0 ^ @  Y!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="f8k_110122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anika.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="f8k_110122.htm">f8k_110122.htm</File>
    <File>anik-20221101.xsd</File>
    <File>anik-20221101_lab.xml</File>
    <File>anik-20221101_pre.xml</File>
    <File>exh_991.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>graph.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f8k_110122.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "f8k_110122.htm"
     ]
    },
    "labelLink": {
     "local": [
      "anik-20221101_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "anik-20221101_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "anik-20221101.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ANIK",
   "nsuri": "http://anika.com/20221101",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "f8k_110122.htm",
      "contextRef": "From2022-11-01to2022-11-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://anika.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "f8k_110122.htm",
      "contextRef": "From2022-11-01to2022-11-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://anika.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001171843-22-006969-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-22-006969-xbrl.zip
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M)0>PV29&$P5$BMT90$@M1J7:SPO:9?:(>I%5_NX0V$!([OAU[4[3VEO;5FU
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M.3$N:'1MS5Q;<QLWDWU/5?X#5MGDDZI(2I0<R[)EUT=+<JQ:V])*<ES[",Z
M).+A8 +,B%)^_9YN8"ZD+C;$5';]D% <<J;1E].G&PT>_L?QV='5_YR?B/=7
M'S^(\\]O/YP>B8W^]O:7O:/M[>.K8W_AV6!'7%F9.UUJD\ML>_ODT\:;PUDY
MST0F\^GK#97W/U_26TJF;PY+76;JS4DZE?:=SG0^/=SV;QW.52E%8O)2Y>7K
MC5+=E-MTEU<BF4GK5/EZH?/4+%Q_N/OK[H;8#M_(Y5R]WOCMY-/)Q>CJ[&*C
MO<7'2Y;PQ6!G9[#_?&<X&+[8.7C&W]SVPHQ->BO&T\1DQK[>^&G"_R!J(5QY
MFRDO15]F>IJ_%%9/9^4K7)W@ ?4'Z'7?Z;_42S'<*4I<';\YN9GIL2Y__$%$
M_#LX& P/M\<0C6Z)_Q4/B)%@;<I^CQRC7'^5O_ST8G>X_\K%27,$P\CLEY^&
M^\]>B<LJ291SDRK+;L4HF6EUK9PXMWHN[:TXR=/":$BB<WS^^<ZKJYFVJ3B?
M2:?$Z>FIN"RK]#9R:?P1^A1?>;WAKWQSS?H-/TP<J[G)76EEJ5*(7RBKC=7E
MK3"3L+2>D.(2KS+5/\W_4 DYKWA_*[/*FEPG6*9.^V^QA!2*^UV[Q+BJ*#(U
MAR#BR,S'.L>M%[J<B7?2E?T1[I!/L59EC4Y[XNQ:V?HO,<I,KGIB8JPX<Z4R
MTI8SB*.A1*ES<:$RK29"EF+WN?BBU%=WN*UA0,N>VNA,B*?J(\[V;RN=I4Y
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M_8/=%_O^RCP/TO^[Z6$_KCQZ-_R&Z/:W#+I-O_!*/_=:SK/:)O\+4$L#!!0
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M%     @ +XIA5>8?;E%JBP  N+0   D   !G<F%P:"YJ<&?LNP=4T]VV+QI
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M<C?Y6]A?:G^I_:7VOT)-YMM6.(9:<75D[@:MW\6B[+>!5@WLG GAJ[NX5G(
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MTZX/,)FU%,H9M#94\$9PFZ<W\IDH9I\"NY^7Y;)E;+^N=F_Z(!O[\-?C2\<
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M3H+O'<GGJA<3U #]Z=?S35-8$),>-C!,Z3O3T!64CP\MR'\ !%;R.(!1L]0
M&-=,T@?]UN51D_J-L9]]<J/R>F2_TD&(^F-58H;5(U6"<BW$HO!JAO'>G'4Z
MX.7[%E(#=F9FY&-SH:SMF0609ZM?8?Y85G WSWQY^ETD?EEE+HD/&4!VA]M=
M(=."+N? &7E-#>/Z(6KK![+I^2 M&W_N=@:Q9/U"\WQ)1I$3(1X\_&1.1^5(
M :#4%W.<H$0QM[8PX+)[H$FZ/2[:HH]1O0Q$X39YJ2K.)01U0A?< -&D>M5*
MW@'.8U+MLB&QTD#Y)Z:/^'S!2G>ZHCKD6G'B8A=O1@!E9'D>&IU4!^9CAG@6
MUA!&/ 1-/3-I-LL[ CV-2H)@@VNM)ZI.Q8SF8JSL,0<S7(SF7UEE. 9C!I[D
M57>? -%*1HH7Z-*TXPU+1BR@)3<2%9]12#+AHD3UU[AP<; @5/P&SD3".>^$
MIM;$]@);/5JG3NJ+<[>-6F<JY@O*IX[X!9)$J8= HKZSA4&[\X?%$4NC=^"+
M2H@,?)'3UPDLEPCD5+3$)E&O#F<4R_:&X87'.7A!$Y='X+)^4$V;\!+PS5AN
MM)&Y@/%+UU-]%@0T]<P!2%D@0(LK"=MK;!UWV31?_Q'I-99YP/#+.8[.2<L"
M5Y?K)GSTKA!J*=C J>"\63GUC=VMD?47B1Q)YZ53GQ1;1@L(6T;3YW-P<NK&
M2\M<4NWE DN8B':2I=:-8DEK ,DARHB(O]/P!1ZW''M?AX(:HY2D*M.VJ]Y^
M(&]TYTF0946U?"9?FG0BB[XB9_[-O!9^4E5?AC@4/0(!YS,]UN3&4P"C(PU>
M;7V27RIEZOM*AI8+EJ% T=(=H/N=%.:^U E;1TO0)7Q/HX+<N; :SWL!+K>G
ME,BCS%&EIF7]O@$FKJZ9B=E+)&E,/2551^*G?F*G?AYC3K+3!-[&/=,P;X1<
M*R0.['W*&2G\&PH(3.D@@L+2D5R4##X]HE0</D76J.>[4<\)A0G5V\,INNJ,
M:FMD^SKEMN1X?%:WT-(;$WL/,R%ONC3%1SK9DCQDROL:XHA%3M;A0/W"8LGG
M]6<P''IBCT12\P:\H^-G&:MWL)"PR*.*ZI4.#-;1SB6,^ H/.)'<A2%@]R[]
MZ 4';<G1NF&41;!R$+A2MLH"4:@,&ZA9:O_07WX 3%OW=J7+E9:P2<Z*E<,;
MQ>V8<%1M@%V19A%X F=RVA;=6?V:\DGNS63=WS_*K#&K4HM%G'.,^-.@*"E%
MD2Y-/EPWW3P6GF8:*TDZJ=IQ=0R%^H@^0!8C#"AWAOL<A#IT5A/NK:RU[I;1
M_')(;646O9LUFXK'@,P$@,(L!6LX4Z)^Q,=0.8K#6]C:HA%DL.&P<;CRPOI%
M]A.MUXUTGG"P&=Q^?;NQ:C$O,Y$?#ZR?TH&>()T"<\%P\O07SE'* C\45D+6
ME7OPRX/V]8X%EZ>8=C/,-(HFX=EV"NLWV:3&>./Y2&^3*R;O\&I.?%V9[];]
MT>CG#GML?TW^@H3;'E(%S94W=L&0?,,&E\:',@HMA)GQI.>_AOF(SPTQ@.JG
ML)3Z23![7K24CE&T!$[V5%1L6-0)XRG5=]F(50Q%^GYII6WFO6%K7P/;HJSF
MT0OCD?".IV$G@9-\N#F=XLIHNIN@2F[:F@MO"EJ#K*2(DEONFXRBA<#T'!2Y
M;^1+5C53,<-P&Y\VG0VG?F>0"=]Y2R_G,0'_L] $@/;(&@+BOK,$)W_)-RJY
M6IFS%XC">#6C7<J#C20R8]83(=67STOO"?!B4I^5PPMHZ<ZO@U.+%*?6=<GB
M$A4@'VDQ<\<@?@P@Y48^A/RF#%RL_X!\*O[R:G._>U*?1;141@!8)2^1NQL4
M=FB5/RQCSB'LF"M 8AO ^_SN9&M%GJ%G'J06]L,D;VC=?[<8#AIV&'G'I>:3
MCDTU4W!X7J8#RP9VY)W4M224CG+Z\Y4,H?*;$FKPSP:*Q*HM[W0]-BW_8IE;
M^)KA8[_E^TRS6)-TPR>2V2>&O&]K\1>?<Y@TM1PLHJ7H*%[4\4U]3"=) 6*4
M97][$'Z0I'5R\N?D))9IN_?;8Q*12UV4M>$E2@'<3,4LYDF^?CL&AA(7/PH#
M;O)( ]U$.FR*WY!?#T GT+_'C#8;MC1D!G<V"P#\X5L:R(R-[&+SO-<!QCSZ
M5T64Y*06B]=JT!')&_UY.8#S4F-/2+JAZSQ("1;4#NO)F2>\SS:]J[L9R43B
M:/$BW;AEC6QS)^UMV1"HCK^D/5G:UN"\?[3F.;E.$/*:*UMS_,L;Y#K^TGA5
MV;%\M;3\!M'(&:A\O;4HEHM:H(.S9<J68$@>*GEJ)3T\LBCLD#'11R)[821]
MNJTJ.VQ2SJ\LAG$\"VRK9>'IN4P^4WBC1&!46T9A$EM,V_!M]!(%232ZFSY!
MBW>&!:IX#2&)O+RE'I9K2RD>9/+MFC@CI0$,#1<0Y!@T'\:1(4QR&V+OR#?/
MHYI\5.EF4E*HG7^5B<#?.6RW:)AJ"4:UUU@8%;^@(3MM9 =)/?=IJ;A= Z?@
M068?:T%W*WHS4X#LQYL7^M7M($VFX9+S850P=YU1@'$S,5FC5G.!:P'FUAW.
M9L1D GFD4WJ-2Q^2S>?W6>AB7@LP=1;%D9R<$D?&F.=;$RG%1FQDSL7>VST[
M KK#L^#Z77F)U-_+]1A'S)%P<L[K:3<D")>:O-A7?_^4*ZLH_6ZFHVI$=]33
M5 C,#X@7063&=-G 0H4!TIFX&4H+?9^TA?Y7TABI-P1KB6(BB79G6S(2H!"^
M\C/X=>74K.NW_HY5+.Z2-H!FE&!=AW]Q17EN7SH"@M6V,'"/H*EAY?72S![)
M45*0M(?5$O1);W<VC8MB8>53:\6H@&^3\4P8XW&H,^PW"!9ZWQPY-*R1ERB^
M[6R>?/X-_:\_X6[S/PA]6=LE<^G0PCY!P(Q7"?[MAV4.0-T_:BN]Q!)5ZQQL
M_9])N&6J9X.B>L3[W'RP4KBL!_ A!CNK[5+@IBN*KXL>[EO)S$WV-"4!]7P=
MQ'(.O:"(L0>9)\:(0\$]U>;)?"ETS0! \+@WMWL#\7 BIJO?Y@HF #[1VU0F
M02JFS0.9@;@=DF3O''Y._PM@6B3LGJ'ME]EVAJ'3KILY&N\!(71;PG[=]P"G
MKVL55@9]<J!;.TD)>"?\$: %^)K0M-@6=C)/9'A<\VX58(]A4GTUX2O@KR[^
MZN*_U,7VS,"$GT>??[J7O-Z3%&)#ECG9K6^':EVRE_/X M_U_V$J !,C5PND
M$MZ7#WWH&N79^DJ#X'K0LTU.@Q->0YJM!,V],6NN=#G_'M+M^[6.FS;=_?:(
M+1[9$&\F%75@.PCU 76^N%:A>2WH-.+/,^G2[08:Q,5KYRD &?8OW1+_W>+B
M5MJ'?,W1MY-+F\&;KA/[_!:9\H,CJX-I')'GPHC'@*YK51]^-+*:;F(SENN<
MNTA6MG'+UKGIDLBYS)C$#-L&)X>)9OPE^HO>U%M]].__NRO)U9T5'^W&^T\Y
MEN]K<=N'->=7/HMD]LE%W,WJ(9/$Q2S#M=C1BG,7S@( (DK?/.,B#M]8](Y/
M8XS<"C9-ZLO)_F,;(8:L/WHE9,>?[N$,A^@^MO]ID\)K]\\$\E_%X<^&JEAT
MD<Q!_<^EWS^R*;W"58S"[.D%1/7>7J69]/B1,% X""RS_..Z^ZF]F>%Q3^EX
MEN^S#'?UJ_43^2TW2@FI-T/6D5U@Y%)W0#QI;/ $6"7T1)F\$!,#=MNR?!]^
MEV=\YEGS(\6EQKBW/J^#O92X4-43/J9\3S(RL5I7#",8Y_X^SA,&HW?]9HGK
ME%^.W8=?9[^.I\FK?<P4>2YT<'E23?EGF$K7 \U,IO<RCZE-1(1H7REPC7)V
MA%X/7(E8X6_N=#F7,%UH0UZ6:WTNP]9L-!+%W@I@>(5 WG<Z?#.<B3],1H84
M\J[8N^[D-(@AJ,;'@((&G)'E^4$ENNU<S>_7[.E6<T]NMFONSAT%G<RY?_XY
M8/==^/Z<2/#G!ZT,[[1/CX<%K[XZ^'SZ+]7_U:K7_\B&N2U: C]4OM%#+BL"
M+67<+Y[I'!-,FK34<X)*-!,X91CY'>G/[N0&Y,Y-GC\&O.DXK.)CL1 C&#V>
MT28PQ]QG\G-SU,>PU<3UJ<C(8'$PZY*!=_3S=/C_;LA<O(G.-\J$'7E?FL1:
MP5+K$#:1';XFGHOEYJUXKB_V=P:"UNE4 0SMJ"6BGLR;\:L0U7S:G#+YDC@]
M#/Z6R]HF.?UVS,W'ET7V2-V.*JJRKMODK^><V94/QLMAU @<&')K-^XSU4'Q
M^I]EW!9W41M I88?NF%RU_]UT,A\,3+AC(AI3&[ GC04]1;O]ZF>^&+&]\&+
M,N"EYC0+0N=51L@=T09\-/!1X5I)5$][B&# BT<'[*9[K*.V]BO'@$]"-?LO
M9U^T'$Q_@'YSI7/_^WOIHIF>0W(^%N4-.J*J[%0EZSM*?(Q;]:/KUR4&AFI^
MQ5#".I_<G?0K?6>>;SD'*3=4P<>X*Z;[0M'#R]ZI?0AW4]VA<NAU9@> B.BW
MJ")*AL@GZ=..J4Y*YG$;(Y&.4"5FEU^&[P BC3-M%8:4C^_YEL5\-RZO9[R)
M@2< NS)C?$S5#%S7X02HHL0>ZW76RW_6=+)4_H><-T:K$/L"Q*$A7I6N^8,Y
M*/MEGQ"=FS8#7:%L3.5AA6!HZ0GLJ"3".N&%#U&RP>RV.[8;L6!"._)T\;8R
M;0VY,_((,#569]!FGM^=;E^XRVXQ<*@O@_%$ETG3\*'W](PLG3AE#)G4 (2_
M3>@7-PDB+6@.IZ1Y:F#OOIYU>EAX.*K0CE/R%28CQ9C<9AM?R@O!%^H2,5KP
M&H&8U@\R;EW7),,$<IYU\&6WO C<:EPK;H B$W(&?"6IPT5)O;B4IWJ$D3O#
M6IH7)+V: [236S04#N!&S@?Z!M&#4(]8Q8!/E YBBKRPNVEYVI&L?]A4&$#S
MX2=NYM4K*FA3N)H*7[ZTNOV 873/%:M((>#1=?;>1D%8M!ORE#ZCIXEOS;1;
M^9M<?-_8<&_"D[QH"O J=U(_6U?T3P?5R%'8)Y&-G OLI:19K5'-ZX(6T-9[
MI4%AJJ5I0=\07P!8"_DOV^0%P&2IW>(,O).N#M'2W5P<Q>!&OIL88':&Z:_F
M_ULW/Z/QSRSR7X/0[]K7DICP=7(L%<< /?1^R8=Q=L5\8#=^63U%I83R'=W1
M#[F3%8KL11: @>C:KOL77]/_)I4M"?D^[_&3%?HTHV=M?J>-,1*12T(N8Z^,
M=.!4G+WD_I,T@VP! .KOKB# ^/;X0FL_3"AJ,0K&"<)Y3'L,5 'SLJ$5*V;,
MZ!MI;PSH<W5FPGE*"99WZ@ZRS9LW!OL&^$N*!;GP'CSW+8UU;V->49(=GA I
MF&ZCTY2*,?B%%JA>3!VD&)K?5%$PO%*IOFB /$7MBS:IHCTUB<BQW-]^?NDT
M54R1-0]P6OE336[=O2K=AVR!S%L]W0N#H)5KA^UJ][)0J9D\Q96.);+;P0<'
M;NO;VK-VNBS8$93QG*E(W+/T]/D=1X:1"W^6/Y1N^>.E>$>O1+>L-N[57/$N
MH[;U7-7"S&;P$BV%,:/6/ LF8F^%,S<Q:2HW95%Y7F2U&]4("-'IK402^NT9
M=4;@;@VI3U3,:#6-@R2VDDGE?$(^Z0*.R,_I?($[[!^#4 [X9#9U-%;Z\7:"
M4:71%\S!SWO/V%';V8Z39FJQLVT@;Y>1C8L<D9X]V*@=>Y\XG@F@<W8W9^X-
MH)T( ]W'/^UL^$,<S7 ZR&WV!&@/.4HR4=^YD)6Z.L3BACG8RF>6S+DB)(Y!
M9I6N6QS)0L& 0IN6D0^40U_9Y_T/0L9 "ZOR(<5=8\[!F YXF6R3XM(/[^X"
M!BQR5&#?X*F(<TCB@(J5TA9/!:DIH[P,9KZ_Q2EJDZ17(71NCOYOY.ED5X44
MN (-UC$:A"BU1\5&#+3?>-6$O5<D\3YUJXL/1?82KP'!"L$AVI2XI/G;E3H6
M>3NKX%1@NX/4/7)>-93\23J1T4P[=0.;SP$)]GJQF !/AZ4NOB5#?@,@_O3T
MO0<7SFG4%2/'/-Q-,WVLR0W;+@*>.5V=C91NKB-=^.,IXQ(SHU"9X*L[9*HI
M%IB@#O#T!@A4*G2D-Y9F@]P/UA'-F2?B2K73!X,OYN\DL?,V"EK=M3+=SMD;
M<YQ7\K <U=:,#S9T30$]6X<)PZ)&DMWB;G'^-& 8-['"7%)^BL2E"?A(%$V#
M06 8PCHY.=G!R8DA5Q,>[%EG>UWHB\ER\Z@/P*_K2NJF12?=.YY95(75F9-_
M5?]5_>_5IX3_B +3&"S;/M&!X=N[^OD!X^MKR$ST<PA)\'-N3R$$WU&TH$3$
M&UC/#]&%UE6>-I+RV9B>4D^FN.R&6L1GH(+YB*%W;-+25&U[1XAQ<2?^_F<)
M#G)T:N-S2<'X6CDC\\N;@^0Q:JNZA1RE@B0G<1\$+#X?%V:^E<FQ4SCF/GJR
M4LV,M_/KR.5"V/3ML5QCIVZL^=C'"2/P14L"O]KD%\WK3M+=3=*C KK?G'WE
M#(3Y=%STG]+3S[FCE5.@ICTH7)$ ;M99*NGQ#?1\9RS@[$T K]P$Y6G#0S/,
MZRX.21W+6_R@;Z?:@\]ZQZ$"I"NZFZ>J&[BAY>E&4ZB@9XB[ZP+C"+2;N*G%
ME4QN*R9[=K6D>^J#^I31Y\;Q'A"T,XO@J5BZ[Y\D==%3C&5B8T0:1+'_T?H\
MG>*?Y%?IR_X=6__&P1:S:24$[>%E]C#/?Q#!1/ Y=AF/*>V=^D$@CQLJU6T]
M>3K@9C+00K^B*,O'%(B#G9D%>:DB%JSG7Z,9W"9G"7Y"#R%?11ZL?WWA-NZ1
M:X)LLW^Y>:VL/U,D00O E?>/=__[^2:B7$2=>_,M*UTO)]Q"/< WWSBX1@E<
MJF4T&Y_&U=ZOY'MYB.']O8J"[8/9_&N>-O#T=+Y,T==9J4L%T(H>[P/'(&JH
M=+/MY?9&@&W8GS0Q?\CMF$.R&_1+$1@":'A_Q/6MVK[*]/9%1 -*-3481B19
MYQO8*9P[K?2.>%@O5N+CZ/EBK8RT*F)\E?:UN$7$_FVYB*\T0:5.+2*7&7?=
MZVA4R>.* S64KU@#G-<\.1O.I$L.I8F.\]2JR%V"R")( E5C_*EJ(DS69_X-
M'SF.6I<8%1LY9H,NHQO#H=P\P]HF4L> W#*5"WCGH<[/W4^YAAA09JTR]7;O
M;,)A96T^5%'4\W$\&:OOAKA[1R-93C!I(F:XX ;_\MNX]\2].;J;Y;=41\4^
M-&\0NF@V)?T17;XQ/@L%XE+DQE2J=^J4$<Y0N!NF7Q$\T-LMK'X=>QG R_X>
M$A<KD$%HC2BI^TZ"B%W[Q''?07-".]SPX0=]SM5&3 2YG/;,IPYG],&-WKDN
M)E%8X.OGRR)A55M'5)MO*H&96..8T0=%Q,'25U>=-GL,I&&G,F%Q0Q&;<9^/
M 6K5OUQ95Z9.IWF5F9UC^JO\J_R?*%EF_S"@<"=;E>><EW&V:&/58KZI$>Z
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M,\U[=U;C!G<IZUZ#GSLO2J]Q;5C0(A&L"H09\^0RCHH/+>?N7[,(_INUB_M
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MT+&4:4*2+L\-1[M(BY3('+"_X^H^G:GD@YG]FD/SKW@1GEDBE-ROFS1K!A5
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M.B7&OWU<XA]E^'O:2QVVZ8[EQM3;]F21E9C"K;2X=P>SUO41J,3R(6)'CSI
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MJ^-E@6$<L(3TU9# 5C318@AI#5XV0;FGLU0T_1AEFGQ1W)]UM&MXT&NE@A[
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M/N2]</4[_W/[3XTT.\=?J@($I"1YP+5KUC)P/[W/^O VQG?S*P$O9S$'T-^
M4< O&;_,7_3&)I>/;YS[%_X_0;G>,"!*";V;-R'->)SAU:ITB%!(8/QR_:7Q
M#KN:4?ZOI__5WRQSC?A8+7+S'\N:A#C;3O'I.">TYYS<(D7KD  1D;TP^\^S
M8G4PYA#&4R;*CWP77Q!:S%IT&Y<%-.@-YO--.Z1&UKHL?TR.9%B"/3/XUA*P
MQJLE],2.%J68YKH:\\K1A9&*HR6T"3MQ2EOOEARA>K%D[7H/JF*?6HQ)V5!(
MG M3$U(Z?V*^ST4C(."D+GJVQ%F<'F4>VM9-KT5M/@1N/,C7-M1])JAHD&E
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MKLZ]/O\WJ6[^ %61$2%]J[#Y'KS6O$I)<EAJ2J81$8&;#$E2B^ZMS3$9?I3
MNG-23X!#XKQ0?@.X!R\AX'%6H2$UM<>HN> ZH6C$/FJLL!TR)T\S\V>4=/G-
M(8PX=7JJM(R+77X/&[HVLR)_:J).^E0 4;^[O-B>0O>7NG^!_Y6/Z ITM$X%
ML!7"B<-0,,2PP[Z3+!G@B*A $,!VS@KYX$+@_IGS K/_T'2J C%">HF\"I'2
M\B(VR5.Z5EAT0VI(QDCJ$$ZW!LF.AQI?>W;2X#\:EI!/H*H6;#FS7=]0U#%A
M;+& 7H1?SYIP\%+%25>;PTU7<R%)+C.J+1),*[?MR_(&UCME6$(Q"\D@]HH9
MO2T4Z9+P0B ]-&@[NE_<X-[\(.=88X-.<NSPI*>!8^=?!>A;EE-=(<:PN<8&
MTVS6C$B=K!T-%L ?=[?^#2#W9DM'(/522<%[SXH&DIAST.GR^N4%+O6%C?.<
MYKP8N/MN2>,Y./.QZU3>^(6Z>)&QX$YA18O*(8D8;2T+5Q/FB(UND\48Q3C8
M M )^\PL:;B(T?HW@# &1%/K&I;ZL'.F3M(=E*0W$8[8=1:06R8<N,&O("DC
MPQL)VD> <;@+$IL])N09LR5%PVIOY/(H3]> Y <EN=3Z,'@RLB>14+_UQ)B)
M.R>8.?K>6"-_[89)(CMD+$E#P=E3%>'L]'U4IS[C7B71JK\<7<?;'PL:R@&(
M2+>\*N3]WK(I0>=2N4RU8NU5*LY_%<[+<2.?O,;XJ-ZM/*8'8E^WW-$]XF1L
M0.>3JLRMIGZ>=S)P;(G7#AN];1YWRV11TX-EA*NZ.?VC, )I^4'-<P+:=?6K
M+F>A.A!I?D9PVXX_>^;&=+29Q##%V(FIK#P+&C2BE#"%M>K=4AD>9M^YV?4H
MF"H6>!(OZ&PV1R>*%!>*F%3<.BOH:>"_8Y>LLB6;HJQK(>C!H$L6C[QZ\73%
MR@P4Z/6HAR#>L-F2^LF>G<_IPR7+M2 J]!##._!*RXH 0;)E\OM[ YYQ[VR%
M2_'6[0EF]8UTG0^O:&0!=15EZ8@G>($RD=9 )[,6](2\,%,[LA^'8-I@F'_0
M:O3@[MC:A5,&:^('S%"S7OC *3)T[\R#N_D=-DF_&C@&R$ROB\]< YSNRRE=
M$IDH,[74?=9[7X4](5:,9%!+3G0455>YAH\6-*0:4"856W)&B*4#MU >+TKE
M9E\TB VX)(]O(%8<9"=& NMK%$+RJBED(3[V;TT2J8<EGH6U?<GCIO =B74/
M2<7Z_AH8UJ,.I(UH/X A^_7R#OF%)-^YZ;JH*&76F-^ACL K^_(KRGL]-;71
M"[W7LU66T?;U<"FJT:F"U6!JS;TQQZ.NTNN^HI<_7> "/Q'D5./'T1B.]GEJ
M9058["KTX,P,WLQW/]44;\-NGSELT*P<%C>1J,U@?0]8E)DK[;R_MHL#6=SD
MRMU$#;V*B+8XB"_?@8J(SM$\$X4<Z#JAV4,TBH SUY&*]?K0M<@S"GDC6?YG
MA\Q_7KOR5RV_<]-)S(S\TAA235T2BI1,H7^%TQ1C5P2Q\F(<^V_)V,T6=)&A
M:F?IS[CO?TS\+!&J2,2**%J4Z[I$=LF3:P=\Z)\TU9$BK[X=R"R,$Y+MG:AW
MNC)9O_;55#W#N]3;PO@6,B0;RT4_YN.1F5&4]D%M\;%^[,;9#X\QY=>LRAI
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M+3(P,C(Q,3 Q+GAS9%!+ 0(4 Q0    ( "^*85664YSP_@H  ("&   5
M          "  7L#  !A;FEK+3(P,C(Q,3 Q7VQA8BYX;6Q02P$"% ,4
M"  OBF%5\X1&#5$'  #/5P  %0              @ &L#@  86YI:RTR,#(R
M,3$P,5]P<F4N>&UL4$L! A0#%     @ +XIA5>H(KTL:%@  VE8   L
M         ( !,!8  &5X:%\Y.3$N:'1M4$L! A0#%     @ +XIA52P<'^T$
M'0  YWT   X              ( !<RP  &8X:U\Q,3 Q,C(N:'1M4$L! A0#
M%     @ +XIA5>8?;E%JBP  N+0   D              ( !HTD  &=R87!H
:+FIP9U!+!08     !@ & '$!   TU0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
